Scientific - myESR.org

Transcription

IMAGING 2.0
Philips Imaging 2.0 is more than an evolution in imaging, it’s a revolution. It’s about collaboration. A multi-modality
approach. Providing advanced solutions allowing you to focus on better
patient care. Join the conversation at www.philips.com/imaging2.0 and see
how our revolutionary innovations bring greater simplicity to healthcare.
www.myesr.org | EUROPEAN CONGRESS OF RADIOLOGY 2011
Table of Contents
General Information
Scientific Programme
4 Welcome by the ECR 2011 Congress President
8 Le chef vous recommande
11 Your Timeline to ECR 2011
12 Timetable
92 ESR Dignitaries
100 ESR Executive Council
101 ECR 2011 Committees
105 ECR 2011 Topic Coordinators
Categorical Courses:
38 KISS (Keep It Simple and Straightforward):
Musculoskeletal MRI
39 Radiology in Abdominal Emergencies
40 CLICK (Clinical Lessons for Imaging Core Knowledge):
Common Clinical Cases
Scientific Highlights
2 0 SA 2: New advances ensure imaging
plays pivotal role in ovarian cancer
24SF 14: CT’s unrivalled success poses
dilemmas in thoracic emergencies
26 SF 15a:Molecular imaging for radiologists
32PC 10: New bridges could help improve
cancer patient management
36 CC 18: Common clinical cases in a click
42 MC 25: Europe and USA combine expertise
in oncologic imaging
Scientific Programme
14ESR meets France, Brazil,
Iran & Gastroenterologists
19 New Horizons Sessions
22 State of the Art Symposia
28 Special Focus Sessions
34 Professional Challenges Sessions
Coordination:
ESR Office, Neutorgasse 9, 1010 Vienna, Austria
Phone: (+ 43 1) 533 40 64-0
Fax: (+ 43 1) 533 40 64-441
E-mail: [email protected]
www.myESR.org
Managing Editor: Julia Patuzzi
Art Direction: Peter Baierl / Robert Punz
Layout/Satz: Tine Ulbing
Printed by Holzhausen Druck, 2010
All data as per date of printing: November 2010
Photo Credits:
Unless otherwise indicated all pictures
© ESR – European Society of Radiology.
08 © photocase.de/3quarks
23 © Julius Silver (Belvedere)
30 © Julius Silver (Gasometer)
35 © Julius Silver (Oper)
44 © Julius Silver (Stephansdom)
48 © Julius Silver (Gloriette)
58 © Julius Silver (Fiaker)
73 © Julius Silver (Karlskirche)
89 © Julius Silver (Hofburg)
90 Tonkünstler im Musikverein © Werner Kmetitsch
92 Akademietheater auditorium © Reinhard Werner,
Burgtheater Wien
Mini Courses:
44 Organs from A to Z: Pancreas
45 The Beauty of Basic Knowledge:
Interpretation of the Chest Radiograph
46 Functional Imaging of Tumours: How to Do It
47 Essentials in Oncologic Imaging:
What Radiologists Need to Know
48
50
51
52
54
55
56
57
58
60
63
65
66
67
68
69
Refresher Courses/Scientific Sessions
Abdominal and Gastrointestinal
Breast
Cardiac
Chest
Computer Applications
Molecular Imaging and Contrast Media
Genitourinary
Head and Neck
Interventional Radiology
Musculoskeletal
Neuro
Paediatric
Physics in Radiology
Radiographers
Vascular
EFOMP Workshop
E3 – European Excellence in Education:
70 Foundation Course: Paediatric Radiology
71 Interactive Teaching Sessions
74
76
76
76
76
77
77
77
79
79
79
1st ESR/EANM Joint Pre-Congress Workshop on PET/CT
4th Post Processing Face-Off Session
ESOR Session
Radiology Trainees Forum: RTF Highlighted Lectures
EIBIR presents: IMAGINE Workshop
Standards and Audit
Image Interpretation Quiz
Hospital Management Symposium
ENCITE Session
EuroAIM Session
Junior Image Interpretation Quiz
Update Your Skills (Practical Courses):
81 Image-Guided Breast Biopsy: How to do it
83 Musculoskeletal US: Shoulder and Elbow
85 Satellite Symposia
91 Industry Hands-On Workshops
3
EUROPEAN CONGRESS OF RADIOLOGY 2011 | www.myesr.org
Dear Colleagues,
The ECR is really something special!
Of course, this is the place where attendees learn radiology
in all types of sessions from foundation courses to advanced
presentations. Obviously, it is where renowned experts,
extending their teaching skills every year, share their knowledge
and experience with us. There is no doubt that it is a unique
opportunity for researchers to present their scientific work and
discuss it with other scientists. Unequivocally, it is where the
industry proudly presents its many technical advances.
Yes, the ECR is an important scientific meeting. Yes, the ECR is
a landmark in our professional lives. Yes, ECR 2011, for its 23rd
edition, will be a scientific and educational success.
However, the ECR is much more! Let me reveal some facts and
thoughts. Since its re-foundation in 1991, when it was decided
that the meeting would be organised every year instead of being
biennial, the number of attendees has continuously increased.
More importantly, the delegates come from more and more
different countries, within Europe and outside Europe, even
from the antipodes! Analysing the statistics for attendance,
we are always surprised that so many sessions are packed with
participants, including scientific sessions, which are sometimes
more intimate at other meetings. The percentage of attendees
who are really present in the sessions is one of the highest
among large meetings.
Is there a secret ECR recipe for achieving such a success? Of
course, there is! Today, I am in a position to disclose some of
the ingredients:
4
Ingredient #1
is evaluation.
Every year, the delegates are asked to complete evaluation
forms. Far from being only a formal procedure for
accreditation, the feedback from the attendees is carefully
scrutinised. Quantitative and qualitative data are all taken
into account. Comparisons are made year after year,
watching for increasing or declining activities. Evaluation
provides green, red and orange lights. No red light is
ignored. Usually, an activity that is poorly rated is stopped
or profoundly remodelled. Orange lights are also important.
This information is of utmost importance to the speakers, who
know that they have to work on their presentation to make it
more appealing to the organisers, who understand that such
a situation should not remain unchanged. Even the green
lights are important, not only because they encourage those
who promoted these activities, but also because this is a very
strong message from the delegates to the organisers, pointing
out their expectations. In 2011, I strongly encourage you to
participate in the continuous improvement of the meeting
by filling in forms as completely and objectively as possible.
Truly, innovation is the mother of success.
Ingredient #2
is innovation.
Ingredient #3
is regenerating continuity.
Which is the sentence you agree with: “never change a winning
team”, or conversely “always change a winning team”? Should
I say that both are true? The winning team provided success
and this should not be denied. Reasons for the success should
be fully understood. This is the role of evaluation. However,
continuation without reinvention and changes would be a
complete guarantee of future failure. This is why year after year
the ECR has introduced new concepts, new sessions, and new
formulas. The ECR is constantly remodelling the concept of
attendance, moving away from the initial passive accumulation
of knowledge, and aiming at personalised interaction. In the
era of electronics, there are so many tools that we should take
the best advantage from each. Since 2003, the ECR has been
the leader in electronic presentation. Later, the ECR initiated
interactivity within sessions between the teacher and the
attendees. A lot is still to be done, but 2011 will be another
landmark for interactivity and you will certainly discover the
future of teaching during these days. For all these reasons,
innovation is the daughter of evaluation.
Being inherently international, the ECR has to take into account
the reality. Because there are so many nationalities, the ECR
has to promote an organising group that reflects its ‘customers’.
Accordingly, each country needs to be represented within the
committees, and the voice of everyone should be heard. This
could be a drawback or an advantage. The drawback is the socalled geopolitical balance, which might be regarded as a melting
pot where origin and nationality would be more important
than scientific and educational skills! However, the result is
just the opposite. Because we need to change the members of
the committees every year and introduce people from different
horizons, this is a fantastic opportunity to welcome new
refreshing ideas and new ways of looking at radiology, and also
to enrich the ECR story with different experience. There is a
little secret: most of the people who join the committees have
had the opportunity to participate in previous meetings in
different positions, and then reinforced their knowledge of the
organisation. Not a single chairperson of an important committee
will come to this position without having been included in a
previous programme. On top of that, the continuous overlap
in the organisation of several sequential meetings improves the
continuity and in particular the Presidents of those meetings
work together to promote both flexibility and continuity. I would
like to express my sincere thanks to Prof. Borut Marincek (ECR
2009), Prof. Małgorzata Szczerbo-Trojanowska (ECR 2010),
Prof. Lorenzo Bonomo (ECR 2012) and Prof. Dr. José Ignacio
Bilbao (ECR 2013) for their valuable input and participation in
the making of ECR 2011.
Continued on page 6.
5
Continued from page 5.
Ingredient #4 is expertise.
Interactivity is a priority.
How can we learn anything if the teacher is not good? How can
we implement new knowledge into our daily practice if it is
only esoteric? How can we envisage our future if no visionaries
are pointing out the new horizons? How can we enjoy our
science if speakers are not enthusiastic? For all these reasons,
the expertise of the speakers is mandatory, whether they are
well-established, renowned experts or rising stars.
E3 interactive sessions have been a tremendous success over the
past few years. Rooms were packed and many attendees had
absolutely no chance to get in. This year, the sessions will be
installed in rooms B and C, providing more than 100 additional
seats, and still with electronic interactivity. However, even if
electronic voting will be extended to other sessions like the
CLICK course, it is not the only way to experience the ECR’s
interactivity. In many sessions, the moderator has been asked
to organise, together with the speakers, a practical discussion,
with a significant amount of time allocated. The questions and
the topic are already written in the programme. The discussion,
led by the chairperson, may be organised according to prepared
questions, or even to clinical cases. Be prepared to participate!
The aim is to build bridges between the potentially theoretical
message of the lecture, and the practical application in daily
routine.
Ingredients are not all. We need also some ‘savoir-faire’! I
will come back to that later. As an example, you will, while
navigating through the programme of ECR 2011, find many
sessions that are adapted to your expectations, whatever
the desired level, beginner or expert, clinician or researcher,
subspecialist or general radiologist. The future will come to
you, with the prediction of what breast radiology will be like in
2025, with new developments in CT (the 5th dimension!) and
MRI (quantum leaps?). The future is always much closer than
we think! I would like to take this opportunity to welcome the
increasing number of medical students attending the ECR.
We will hold a special session for them, and I am sure that all
delegates will be more than happy to celebrate the cheerful
presence of our future among us!
Multidisciplinarity will improve.
There is a good reason for this: our daily lives are nothing if
not multidisciplinary. Discussion with our clinical colleagues
always reinforces the strength of our diagnosis. Following on
from 2010’s multidisciplinary sessions on oncologic imaging,
2011 will offer a Categorical Course (‘CLICK’) dedicated to
interactive clinical situations, describing very precisely the role
of the radiologist in real life, the patient with a symptom, and not
the patient with a diagnosis. The patient who comes to you says
that he has a headache, not an aneurism … Multidisciplinary
discussions will also be enhanced in many Refresher Courses
and Special Focus Sessions. I am very glad to also welcome
the gastroenterologists, represented by The United European
Gastroenterology Federation (UEGF), for a very attractive
session entitled ‘ESR meets Gastroenterologists’, which will
decide whether optical colonoscopy and CT colonography are
friends or enemies. Whatever the conclusion will be, I can say
that gastroenterologists are definitely our friends!
6
Overall, the role of the
moderator has been enhanced.
Because they are the intermediaries between the speakers and
the audience, they are very important people. The success of
the session lies in part on their shoulders, not only due to time
allocation, but also because they are the natural ‘translators’.
I would like to thank in advance all those who accepted the
invitation to play this role, and I have no doubt that this will
be the standard format of future sessions at most meetings.
I said that having the main
ingredients does not always
lead to a delicious dish.
You also need some spices.
One is commitment, which means showing loyalty, duty and
allegiance to the ECR. After months of preparation for the
meeting, this is exactly what I can say when I see the amount
of work that has been produced by the organising group. Most
of them, despite a busy professional life, have made themselves
available to work together in Vienna or from home in order
to propose, evaluate, discuss, and finally build the ECR 2011
programme. This appreciation goes to all the professionals,
radiologists, physicists and radiographers, but also to the
members of the ESR Office, who have once again demonstrated
knowledge and efficient support in all aspects of preparation
for the ECR, from logistics to scientific programme building.
I encourage you to consult the gallery of the ECR 2011
Programme Team on the ESR website. It is a real dream team!
Two more are respect and friendship. The ECR is a European
initiative, but heartily welcomes colleagues from the five
continents. There is no doubt that this worldwide participation
greatly enhances the quality of the meeting. I am thankful for
that. We will make every effort to make anybody feel at home in
this European house. This year, I am extremely happy to offer a
special welcome to our colleagues from Iran and Brazil, as well
as my home country France, all of whom will participate in the
‘ESR meets’ programme. These three countries have prepared
very interesting sessions, with an attractive combination of
useful science and local flavour!
I am very much looking forward
to seeing you in Vienna and to
meeting you personally during
the many scientific or social
events.
Being French, I hope that you will enjoy our ‘cuisine’. Eating is a
necessity, but gastronomy is a benefit for the whole individual,
and not only for the mouth and stomach! So is radiology. Yes,
this is our profession, and the ECR can help us once more to
make it a total pleasure!
Yves Menu
ECR 2011 Congress President
7
Le chef vous
recommande …
An original recipe by Yves Menu
Do you want to treat four people to a good meal?
Then try my recipe for sauté au miel.
Take two beautiful yellow onions and 750g of pork, veal
or poultry meat. Do not use frozen meat as it will contain
too much water, which will dilute the flavour of the sauce. I
personally prefer the filet mignon but gladly take the advice of
my butcher. You also need liquid honey, but be careful; only a
small quantity. No more than two not-very-full tablespoons.
One often adds too much honey, but sugar impairs the flavour
whereas it should just add a discrete smoothness, which
combines wonderfully with pan-browned onions.
We also need 6cl of balsamic vinegar of Modena. This is about
two full tablespoons, but it depends on your taste.
In addition we need two exotic ingredients to make the
flavour of this dish more rich and complex. Soy sauce raises
the flavour while remaining discrete. Two full teaspoons are
enough. Ginger powder adds an original flavour, but only in
the background. Pour two teaspoons, no more, or else you
might disturb the harmony.
Finally, we need crushed tomatoes. If you do not feel like
making this purée yourself, you can buy small ready-made
cartons (300 to 400g), which are more than suitable! I
personally prefer the ones prepared with basil, otherwise I add
a fresh, finely chopped leaf myself. Be especially careful not to
cut big pieces, which might disturb your palate.
There, we are now ready to cook. It takes very little time to
prepare (20 minutes), and a bit longer to cook (30 to 50 minutes).
One only needs a frying pan or a stewing pan. As for me, and
as a reference to soy and ginger, I like to use a wok, which really
facilitates smooth stewing. What better way to emphasise even
further the various flavours contained in this dish?
Let us start by thinly slicing the onions on a chopping board.
They must be thin enough to almost melt in a compote but
thick enough to be recognised in the velvet of the sauce.
Let us put our onions in the wok with a few drops of olive oil.
My favourite oil comes from Lake Garda in Italy, in memory
of Antonio Chiesa, who, upon learning my passion for cuisine,
had a tasting arranged for me. Ever since that day, I have
remained faithful to it, maybe as a tribute to this gentleman of
radiology. Let us not be rushed, the onions must brown slowly,
without burning.
While the onions are singing sweetly, we again use the board to
chop the meat into small cubes of about one centimetre each.
As soon as this is done, these pieces will join the onions in the
wok. Raise the fire a little as the meat should be browned on
each side in 3 to 4 minutes, without cooking the middle. Once
this is done, make room for the ginger powder! Mix everything
right away so that this spice diffuses itself well. Beware of lumps!
Everything is taking shape! Now make room for the culinary
odd couple, namely honey and vinegar. Add them to the dish
alternately, while slowly mixing so that everything is evenly
combined; the chef ’s nose is starting to be enchanted. I first
put one full spoon of honey, then one of vinegar and I mix well.
And I start again. My tip concerning honey: I prefer acacia
honey or flower honey, but above all you need liquid honey, as
one of the secrets of this dish is to intimately and rapidly mix all
the ingredients. Too thick a honey would take too long to mix,
and would cause a damaging heterogeneity. Your palate would
go from sweet to salty, whereas this recipe is the praise of the
intimate mix, not simple cohabitation.
Let us add a bit of salt (three to four turns of a Guérande salt
mill) and black pepper (three turns of a Vietnam pepper mill),
and mix some more.
Did I mention everything has to be cooked at a low heat yet?
Yes, of course I did, but I must emphasise it once more. After
the onions and the meat turned brown, we had lowered the
heat a little, as if to gently welcome all these ingredients.
It is now time to add the crushed tomatoes. Little by little, well
integrated with a wooden spoon, each portion has to be totally
mixed before you add some more.
There, the preparation is over. Now it’s time for cooking. To
harmonise the mix of savours, raise the heat for 10 minutes
without covering, to let the excess water evaporate. Turn the
sauce in the wok two to three times so that it cooks evenly.
Then place a lid over the pan, preferably a glass one (not that
it’s better but just for the pleasure of watching), lower the heat
and let it stew for 20 to 30 minutes.
The only thing left to think about is how to accompany your
dish. As for me, and depending on the day, I prepare either
fresh pasta or cooked Thai rice.
Then simply wait for your guests. If they are late, no problem.
Once cooked, you can lower the heat while the cover is still on,
to keep it warm. It will be just as delicious an hour later!
When your guests savour the dish,
start playing with them by asking
them to identify every ingredient.
If you’ve prepared everything smoothly, they will not recognise
all of them. But once you will have listed them, they will answer
it was obvious. Only this way will you be able to assess your
culinary success!
Choosing the wine is not easy for a dish of such complex
flavour. You need one with personality but which knows how
to remain humble. I would advise you a Givry first regional red
wine, a Chalonnais wine that never lets you down.
By the way, did you have anything in mind for starters? What
would you say to some noix de Saint-Jacques with Normandy
cream? You will also serve that with a Givry, but white this time.
Share your scientific
work with the
radiological world.
New and unique – submit your work, all year long!
EPOS Abstract Submission is open all year!
If you want your poster to be shown at ECR 2011,
submit your abstract by December 31, 2010.
Abstract submission for EPOS™ (Electronic Presentation Online System)
has been re-structured to include the following new features:
 All-year-round submission & poster upload
 Quicker review process
 Your publication citable and available online throughout the year
Find more information at
myESR.org/epos_all_year
Your Timeline
to ECR 2011
from September 1:
Online Registration Open
Middle Fee from November 12 to December 30, 2010
Late Fee from December 31, 2010 onwards
from October 1:
Travel & Accommodation Service Open
November 12:
Participate from Home Registration Open
November:
Notification of Paper Abstract Acceptance (Oral Presentations)
December 31:
Final Deadline for ECR 2011 Poster Abstracts
January 31:
Deadline to Upload Accepted Posters to EPOSTM
March 3–7:ECR 2011: Thursday to Monday
Congress Venue
Scientific and Educational Programme
Austria Center Vienna
Bruno Kreisky Platz 1
1220 Vienna, Austria
3 Honorary Lectures
1 Opening Lecture
1 Guest Lecture
4 ESR meets Sessions
2 Image Interpretation Quizzes
3 New Horizons Sessions
3 State of the Art Symposia
14 Special Focus Sessions
4 Professional Challenges Sessions
3 Categorical Courses (18 Sessions)
4 Mini Courses (15 Sessions)
74 Refresher Courses
1 Foundation Course:
Paediatric Radiology (6 Sessions)
14 Interactive Teaching Sessions
1 e-Learning Centre with Self Assessment Tests
1 RTF – Radiology Trainees Forum:
Highlighted Lectures Session
2 Update Your Skills (Practical Courses)
1 EFOMP Workshop
1 ESOR Session
1 Standards and Audit
1 Hospital Management Symposium
1 Post Processing Face-Off Session
Congress Language
English
CME Accreditation
Each ECR delegate receives confirmation of all activities
attended (CME confirmation – Record of attendance).
The approximate maximum number of hours of scientific
activity attendance is 40 (please note that this number differs
from the maximum number of UEMS/EACCME credits).
ECR 2011 is expected to be designated for a maximum of 27
hours of European external CME credits.
Facts & Figures
19,000 Participants
100 Countries
270 Scientific and Educational Sessions
4,300 A
ccepted Proffered Papers and Exhibits
Fully Electronic Scientific Exhibition
Industrial Exhibition
approx. 285 exhibitors
26,000 m²
Satellite Symposia & Industry Hands-on Workshops
11
Timetable
08:30 09:00 09:30 10:00
10:30 11:00 11:30 12:00
12:15 13:00 13:30 14:00
Friday, March 4
ESR meets France
E³ Session
Scientific Sessions
Update Your Skills (practical courses)
(400)
Special Focus Session
SF 7
Professional Challenges Session
PC 7
Categorical Courses
CC 716, CC 718
Mini Course
MC 719
Refresher Courses
E³ Session
Update Your Skills (practical course)
(700)
EFOMP Workshop
ESR meets Brazil
E³ Session
Scientific Sessions
(800)
SF 11
Categorical Courses
CC 1117, CC 1118
Mini Courses
MC 1119, MC 1125
Refresher Courses
E³ Session
(1100)
ESR meets Iran
Mini Course
MC 1225
E³ Session
Scientific Sessions
(1200)
Sunday, March 6
New Horizons Session
NH 3
State of the Art Symposium
SA 3
Special Focus Sessions
SF 3a, SF 3b, SF 3c, SF 3d
Categorical Course
CC 316
Mini Course
MC 322
Refresher Courses
E³ Sessions
Update Your Skills (introductory lecture)
(300)
Saturday, March 5
Thursday, March 3
Siemens Symposium
3
7
11
Monday, March 7
ENCITE Session
12
SF 15a, SF 15b
PC 15
Categorical Courses
CC 1516, CC 1517, CC 1518
Refresher Courses
E³ Session
(1500)
15
4
EFOMP Workshop
8
Standards and Audit Session
Bracco Symposium
EIBIR Session
12
E³ Session
Scientific Sessions
(1600)
16
Josef Lissner
Honorary Lecture
Scientific Sessions for
Medical Students
Post Processing Face-Off Session
GE Healthcare Symposium
Bayer Schering Pharma Symposium
SuperSonic Imagine Symposium
Pierre et Marie Curie
Honorary Lecture
Guest Lecture
Mini Course – MC 21C
E³ FC Self Assessment Test
Scientific Sessions for Medical Students
ESR EU Affairs Session
Siemens and Bayer Schering Pharma Symposium
Guerbet Symposium
Hitachi Symposium
Philips Healthcare Symposia
Bracco Symposium
Wilhelm Conrad Röntgen
Honorary Lecture
Mini Course
MC 21D
Scientific Session for
Medical Students
Philips Healthcare Symposium
Bracco Symposium
Siemens Symposium
Mini Course
MC 21E
Timetable
14:00 14:30 15:00 15:30
E³ Session
Update Your Skills (Introductory lecture)
Scientific Sessions
(100)
1
ESOR Session
5
Hologic Symposium
Siemens Symposium
Sectra Symposium
9
2
6
New Horizons Session – NH 10
Professional Challenges Session – PC 10
Categorical Courses
CC 1016, CC 1017, CC 1018
Mini Course
MC 1019
Refresher Courses
E³ Session
(1000)
EIBIR Network Member Event
10
SF 18a, SF 18b
Refresher Courses
E³ Session
(1800)
14
18
Monday, March 7
E³ Sessions
Scientific Sessions
(1700)
Sunday, March 6
SF 14
Categorical Courses
CC 1416, CC 1417, CC 1418
Mini Course
MC 1425
Refresher Courses
(1400)
17
Opening Lecture
ESR meets Gastroenterologists
New Horizons Session – NH 6
State of the Art Symposium – SA 6
Special Focus Session – SF 6
Categorical Course – CC 616
Mini Course – MC 622
Refresher Courses
E³ Sessions
(600)
RTF Highlightes Lectures
EIBIR - PEDDOSE.NET Workshop
SF 13
Categorical Courses
CC 1316, CC 1318
Mini Course
MC 1325
Refresher Courses
E³ Session
(1300)
13
Presentation of Honorary
Members and Gold Medallists
Saturday, March 5
Opening Ceremony
Friday, March 4
Mini Course
MC 21B
E³ Session
Scientific Sessions
(500)
State of the Art Symposium
SA 2
SF 2
PC 2
Categorical Course
CC 216
Mini Course
MC 222
Refresher Courses
E³ Sessions
(200)
17:45 18:00 18:30 19:15
Thursday, March 3
Mini Course
MC 21A
16:00 16:30 17:00 17:30
13
ESR
meets
…
Portraits of the ECR 2011 guest countries
ESR meets Brazil
The Brazilian College of Radiology and Diagnostic Imaging (Colégio Brasileiro de Radiologia e Diagnóstico por
Imagem – CBR) was founded on October 15, 1948, in São
Paulo, and is the legitimate representative body of Brazilian
radiologists. It brings together about 9,000 members and
has regional affiliates in 25 Brazilian states.
Over its 62 years, the CBR has become an important tool for updating and evaluating the
training of radiologists. It also aims to be
a regulator and to standardise radiological techniques, as well as the quality of imaging exams. The
society carries out
projects aimed at
better understanding the market
reality in radiology.
With these data, the
actions and decisions
of the CBR may have a
greater connection with
the reality of radiological
services in the country.
Since 1955, the CBR, in conjunction
with the Brazilian Medical Association,
has been providing specialists in radiology and diagnostic imaging, nuclear medicine and radiotherapy. Besides ensuring the
educational and professional improvement of
radiologists, the CBR strives to improve public health in Brazil through diagnostic imaging, with early and accurate tests.
14
The society promotes refresher courses, conferences,
seminars and meetings on various radiological methods
and provides informative bulletins and scientific journals,
including the Bulletin of the CBR and the Brazilian Journal
of Radiology.
The CBR organises two major events considered the largest
in Latin America: one of them is the Brazilian Congress of
Radiology, attended by approximately 4,000 delegates, and
the other is the Jornada Paulista de Radiologia, held by our
affiliates every year in Sao Paulo, with more than 12,000
participants .
The question of the use of teleradiology is a concern because
Brazil is a country of continental dimensions; when practised well and according to the law it can help many people,
but we must emphasise that the matter should be treated
with caution so that the clinics always obtain the best diagnosis, performed by a specialist from the CBR.
Other key activities include the responsibility for regulating
and controlling the imaging examinations in the country
(governed by the National Agency for Sanitary Surveillance
and the National Commission for Nuclear Energy – CNEN)
and participation in training and control of radiology residencies. It is also the institution responsible for interfacing
with government agencies like the Ministry of Health, Education, Finance, and with entities outside of radiology.
Last but not least, the society constantly struggles on behalf
of CBR specialists for the best possible working conditions
and remuneration in exchange for their services.
Dr. Sebastião Cezar Mendes Tramontin
President, Brazilian College of Radiology and Diagnostic
Imaging
ESR meets France
The French Society of Radiology (Société Française de
Radiologie – SFR), founded in 1909, is one of the oldest
radiological societies in Europe. The origins of the SFR can
be traced back to a first meeting held on January 12, 1909,
including Antoine Béclère and some enlightened pioneers. A
unique characteristic of the SFR among other French medical
societies is in that it has academic, hospital-based, and privately practising radiologists as members.
Overall membership of the SFR has tripled over the past
14 years and the SFR now has more than 7,700 members
worldwide. The mission of the SFR is to promote the study and
dissemination of scientific knowledge regarding all aspects of
radiology and related sciences, to maintain and extend to the
public advantage the usefulness of the work of the radiologist,
and to promote study and research by setting professional
standards of practice. The SFR has nine subspecialties within
radiology and more than 30 professional working groups and
links with other branches of medicine and allied healthcare
professionals.
If radiology is to remain as a medical specialty and not be
‘bought up’ by other specialties, then the education of future
generations of radiologists remains an important issue for the
SFR. The educational programmes are mainly accomplished
during the Journées Françaises de Radiologie (JFR), which
take place in Paris every October together with monthly
regional meetings organised by the subspecialties sections
throughout the year. The last JFRs were very well attended
and attracted a large number of participants not only from
Europe but also from many far away countries. In order to
promote innovation and quality of healthcare, more than
540 electronic posters in all subspecialties and 300 hours of
Continuing Medical Education (CME) were proposed. To
extend CME beyond the period of the congress, the SFR is
continually expanding its online offerings: the e-learning
section of our website includes electronic posters, as well as
courses recorded during the JFR. Moreover, SFR publishes
educational materials such as syllabi, CD-ROMs and books
on imaging.
The peer-reviewed journal Le Journal de Radiologie, created
in 1914, is published monthly, with six focused Continuing
Medical Education textbooks published in a run of 8,000 copies. Le Journal de Radiologie upholds history and tradition,
but looks ahead to developing and adopting new trends in
modern scholarly publishing. Collaboration with other radiological societies is another important undertaking of our
society. The SFR is deeply involved in providing educational
programmes and teaching materials in French-speaking
countries, with which the SFR has developed close cooperation over many years.
In the name of promoting the development of good practices
and standards, official documents, such as books of guidelines
on the clinical use of medical imaging and optimal procedures
of imaging technique have been available via a continuously
updated website since 2006. In order to increase the scientific
level and the internationalisation of French radiology, the SFR
aims to focus its efforts on some major topics:
•C
oordination of research projects and research
cooperation between institutions of radiology
•H
elp to build a network between the communities
in Europe to support and train our radiologists
•O
rganisation of courses on scientific methods
for radiological research.
The SFR, in association with private and public French radiological unions, along with the College of Academic Radiologists, has contributed to the founding of a professional
organisation, the Professional Council of French Radiology.
The aims of this cooperation are to harmonise strategies in
defence of radiology and medical imaging in France as well
as to present common positions in negotiations with national
institutions and other health organisations. For further information regarding the SFR and its various activities, please see
our website at www.sfrnet.org
Jean-Pierre Pruvo
Secretary General, French Society of Radiology (SFR)
15
ESR meets …
ESR meets Iran
The Iranian Society of Radiology (ISR), established in 1968
by the late Dr. Rooholamini, has the role of both a professional association and a scientific society focused on science
and the practice of radiology in Iran. It currently has more
than 2,000 members with eight provincial/regional branches
in large cities like Shiraz, Isfahan and Tabriz. It has many
subspecialty committees consisting of outstanding university professors and experienced practitioners who conduct
training and subspecialty consultations whenever required
for decision making.
The scientific activities of the ISR consist of holding annual
meetings, the most important of which is the Iranian Congress of Radiology, the largest gathering of Iranian radiologists and related scientists, as well as the annual imaging informatics conference, along with numerous refresher
courses throughout the country. The next ICR, to be held
on May 17–20, 2011, will have the honour of hosting delegations from around the world. The industrial exhibition at the
ICR features a number of local and well-known international
vendors showing state-of-the-art high-end equipment.
The Iranian Journal of Radiology is the only Iranian radiology journal published in English by the ISR, in collaboration
with Tehran University of Medical Sciences. The ISR holds
the authority of setting the country’s radiology-related regulations and making national policies and decisions in collaboration with the Ministry of Health and the Iran Medical
Council, and so defining the boundaries of the radiology
profession at a national level. The ISR is also a member of a
coalition of professional medical associations.
A current major project proposal of the ISR is the ‘Iranian
School of Radiology’ following the general idea of the European School of Radiology (ESOR), with the aim of boosting
the ability of practicing radiologists and those in training to
improve the role of this profession in healthcare.
The ISR highly appreciates becoming a corresponding member of the ESR.
Dr. Abdul Rasool Sedaghat
President, Iranian Society of Radiology
ESR meets
Sessions
Friday, March 4, 10:30–12:00,
Room A
ESR meets France
EM 1From neurosciences to
clinical practice
Saturday, March 5, 10:30–12:00,
Room B
ESR meets Brazil
EM 3Thoracic imaging:
a Brazilian approach
residing:
P
Y. Menu; Paris/FR
J.-P. Pruvo; Lille/FR
• Introduction
J.-P. Pruvo; Lille/FR
• White is white:
a simple guide to demyelinating diseases
V. Dousset; Bordeaux/FR
• Interlude
• Functional imaging: useful tool for the radiologist or
crystal ball for the psychiatrist
A. Krainik; Grenoble/FR
• Interlude
• Stroke around the clock:
will the challenger (CT perfusion)
beat the champion (diffusion MRI)?
X. Leclerc; Lille/FR
Presiding: M.A. Gomes da Silva; Sᾶo Paulo/BR
Y. Menu; Paris/FR
• Introduction
M.A. Gomes da Silva; Sᾶo Paulo/BR
• Granulomatous interstitial lung disease:
HRCT path correlation
C.I.S. Silva; Salvador/BR
• Interlude: Brazilian masterminds
• Granulomatous pulmonary infections
A.S. Souza Jr.; São José do Rio Preto/BR
• Interlude: The world is in love with Brazil
• Congenital lung disease in children:
state-of-the-art imaging
P.A. Daltro; Rio de Janeiro/BR
• Panel discussion
Sunday, March 6, 10:30–12:00,
Room B
ESR meets Iran
EM 4 Interventional radiology:
from scratch to innovation
Friday, March 4, 16:00–17:30,
Room C
ESR meets Gastroenterologists
EM 2Optical and virtual
colonography: friends or enemies?
Presiding: R. Hultcrantz; Stockholm/SE
Y. Menu; Paris/FR
• Chairmen’s Introduction
R. Hultcrantz; Stockholm/SE
Y. Menu; Paris/FR
• Facts from the statistician (true for once?): incidence,
prevalence, rationale for screening, standard results of
optical colonoscopy
U. Haug; Heidelberg/DE
• Facts from the statistician (true for once?):
how accurate is CT colonography
A. Laghi; Latina/IT
• When optical beats virtual
J.F. Riemann; Ludwigshafen/DE
• When virtual beats optical
S.A. Taylor; London/UK
• Panel discussion: Integrated strategy?
What about the outsiders (capsule, DNA, PET, ...)
Presiding: Y. Menu; Paris/FR
A. Sedaghat; Tehran/IR
• Welcome and introduction
A. Sedaghat; Tehran/IR
• How to start interventional radiology
H. Ghanaati; Tehran/IR
• Uterine artery embolisation for
treatment of symptomatic fibroids
K. Firouznia; Tehran/IR
• Interlude: Persian physicians contribution
to the evolution of medicine
K. Vessal; Shiraz/IR
• Interventional procedures in liver transplantation
A. Rasekhi; Shiraz/IR
• Interlude: Persian physicians contribution
to the evolution of medicine
K. Vessal; Shiraz/IR
• Radiochemoembolisation of hepatic metastases
M. Fatehi; Tehran/IR
17
18
New Horizons
Sessions
Friday, March 4, 08:30–10:00, Room G/H
NH 3
Quantum leaps in MRI:
teslas, pulses, tracers
• Chairman’s introduction
O. Clément; Paris/FR
• What will be the standard machine and
field of the future?
L. Darrasse; Orsay/FR
• Will new technologies allow a jump in
sensitivity?
J. Hennig; Freiburg/DE
• Will new MR contrast probes compete
with PET?
S. Aime; Turin/IT
• Panel discussion:
What is ready for our next machine?
Friday, March 4, 16:00–17:30, Room A
NH 6
Not just Hounsfield numbers:
CT aimed at the fifth dimension?
J.M. Boone; Sacramento, CA/US
• Basic principles of dual energy CT
W.A. Kalender; Erlangen/DE
• Clinical examples of dual energy CT
L. Guimaraes; Viseu/PT
• CT contrast perfusion
V.J. Goh; Northwood/UK
Will CT surprise us again?
Saturday, March 5, 16:00–17:30, Room F1
NH 10 Breast imaging in 2025
T.H. Helbich; Vienna/AT
• Is mammography still an accepted modality
for breast cancer imaging in 2025?
M.J. Yaffe; Toronto, ON/CA
• Breast cancer screening with MR imaging
and nothing else
C.K. Kuhl; Aachen/DE
• The evolving role of the radiologist
P. Brader; Vienna/AT
Breast imaging 2025: blood test or still
imaging?
19
New advances ensure
imaging plays pivotal
role in ovarian cancer
By Edna Astbury-Ward
Thursday, March 3,
16:00–17:30
SA 2
Ovarian cancer:
update and what’s next
The role of radiologists is growing rapidly in the investigation and monitoring of suspected
ovarian cancer. New diagnostic and interventional techniques, together with changes in clinical
management and the validation of emerging areas such as MRI of adnexal mass and imageguided peritoneal core biopsy, offer new challenges and opportunities.
Ovarian cancer is the leading cause of death from genitourinary cancer in women. Due to its nonspecific clinical features, it may present to any radiologist involved in abdomino-pelvic imaging.
Attendees at ECR’s state of the art session on ovarian cancer will learn more about the trend
towards individualised patient treatment with high-quality imaging and detailed pathologic
analysis based on information provided by an image-guided biopsy. In the future, the timing and
extent of surgery may be specific for each patient and the chemotherapy regimen may be selected
for the different pathologic types of ovarian cancer.
Dr. John Spencer, consultant radiologist at St. James University Hospital in Leeds, U.K., stressed
that although ovarian cancer screening remains experimental, the trend towards cross-sectional
imaging for evaluation of common gastrointestinal and genitourinary tract problems has a
significant rate of discovery of incidental findings of adnexal masses and other gynaecological
abnormalities. He added that some findings, such as peritoneal carcinomatosis, are clearly
relevant. After further clarification, most adnexal masses that are discovered as incidental
findings turn out to be ‘nuisance’ lesions, but he remarked that this results in significant costs
and increased patient anxiety. Spencer suggested that MRI can benefit patient care because of its
ability to make specific non-invasive diagnoses and define masses as benign or malignant.
PET/CT can improve the accuracy of staging in patients with ovarian cancer, especially by
detecting metastases in normal-size lymph nodes and unsuspected extra-abdominal nodal sites
of disease. Experts are also excited about the potential of diffusion-weighted MRI (DW-MRI)
as a diagnostic tool for improved accuracy of ovarian cancer detection with peritoneal spread.
“Radiology will play an increasingly crucial role in staging of ovarian cancer,” said Dr. Evis Sala,
university lecturer and honorary consultant radiologist at Addenbrooke’s Hospital, Cambridge,
U.K. “Furthermore, we are likely to see an increase in the use of PET/CT and potentially MRI
(with added DW-MRI sequences) for primary staging of ovarian cancer. However, well-designed
studies with histopathology as standard of reference are required to evaluate and compare the
accuracy of PET/CT and DWI in staging of ovarian cancer.”
Although imaging already plays a vital role in staging and treatment planning in ovarian
cancer by assuring an appropriate selection of patients for primary surgery versus neo-adjuvant
chemotherapy, other benefits can result, particularly for the surgeon. Sala indicated that imaging
provides the surgeon with a map of distribution of the disease prior to either primary or interval
debulking surgery. Additionally, it is routinely used to monitor the response to chemotherapy and
detect tumour recurrence.
20
A
B
Contrast-enhanced CT remains the gold standard for staging of ovarian cancer because it is easier to
interpret (due to less intra-observer variability), and it is also more widely available and cheaper than
MRI and PET/CT. A combination of clinical examinations, together with serum CA 125 measurement
and imaging features, may be useful, but ultimately a diagnosis is made by histopathologic evaluation
of tumour tissue obtained from surgery, laparoscopy, or image-guided core biopsy.
Because of the unique properties of peritoneal spread in ovarian cancer (large surface development
at a relatively small depth), the potential use of intraoperative or laparoscopic imaging is an
important development. This technique exploits the refraction of light or emission of fluorescence
in order to image sub-surface tissue at a depth of approximately 2mm. Preliminary data have
confirmed the promise of the technique for improved detection of peritoneal seeding.
Dr. Isabelle Thomassin-Naggara, from the department of radiology at Hôpital Tenon in Paris,
emphasised the potential value of combining ultrasound with MRI, including perfusion and
diffusion sequences. She suggested that because of the high diagnostic performance of these
techniques (up to 96% for characterising complex adnexal masses), this is likely to be the way
forward. She agreed with Sala regarding the benefits to the surgeon of using these techniques,
which should help influence a surgical decision and treatment. “Because the most important
prognostic factor for ovarian cancer is the absence of residual tissue after the first surgery,
all imaging modalities have the potential to assist surgeons when deciding on best treatment
options,” she noted.
Figure:
Axial fused 18FDG PET-CT
images of a patient with advanced
ovarian cancer demonstrate
increased tracer uptake in the left
internal mammary and subcarinal
lymph nodes (arrows in A) and
in the peritoneal deposits in the
serosa of the descending colon
(arrows in B). PET/CT may
improve the accuracy of staging
in patients with ovarian cancer
by better delineating peritoneal
disease and detecting unsuspected
extra-abdominal nodal sites of
disease.
(Provided by Dr. Evis Sala)
She identified ultrasound as the gold standard for detection of adnexal masses, MRI for
characterisation of complex adnexal masses, and spiral CT for ovarian cancer extension. In the
future, high-field MR may improve the feasibility and the accuracy of MR spectroscopy for the
characterisation of adnexal masses. She suggested considering ultrasound in the first instance for
exploring adnexal masses.
Dr. Rosemarie Forstner, from the department of radiology at Paracelsus Private Medical
University, Salzburg, Austria, agreed that where adnexal masses are indeterminate following
ultrasound, a complementary MR examination may be warranted because it may contribute to
improved patient management by influencing specialist referral, surgical approach, and other
therapeutic options. She added that in patients with an unequivocal malignant mass with
or without peritoneal spread, preoperative staging by CT helps optimise therapy planning,
and radiology reports should provide detailed information about findings that are crucial for
treatment planning, including the primary tumour and its dissemination. Radiologists should
also include details about tumour sites that may be difficult to assess intraoperatively, as well signs
that are indicative of suboptimal debulking in extensive tumour load.
To determine appropriate chemotherapy, evaluation of tumour extent using multidetector CT
and image-guided biopsy looks set to ensure imaging remains the mainstay of assessment of
treatment response. Therefore, working in a multidisciplinary team in gynaecological cancer will
give radiologists a central patient management role.
21
State of the Art
Symposia
Thursday, March 3, 16:00–17:30, Room E2
SA 2
Ovarian cancer:
update and what’s next
SA 6
Brain tumour:
imaging and response
M. Stajgis; Poznan/PL
• Ovarian cancer:
update and role of radiology
J.A. Spencer; Leeds/UK
• Advanced brain tumour imaging:
complete imaging protocol
M. Law; Los Angeles, CA/US
• Imaging of adnexal masses:
is it feasible to diagnose ovarian cancer?
I. Thomassin-Naggara; Paris/FR
• Monitoring and prediction of
treatment response
P.C. Maly Sundgren; Lund/SE
• Staging ovarian cancer:
what technique is the best?
E. Sala; Cambridge/UK
• Radiation necrosis and
pseudo-progression vs recurrent tumour
M. Essig; Heidelberg/DE
The illustrated role of the radiologist in
multidisciplinary consensus conferences
Try to understand the clinical question
and you will know which imaging is
appropriate
R. Forstner; Salzburg/AT
SA 3
The 3 P’s of CT colonography:
polyps, protocols and politics
S. Halligan; London/UK
• CT colonography in 2011:
how far has it come
P. Lefere; Roeselare/BE
• Current status of reimbursement
A. Laghi; Latina/IT
22
• Quality, training and accreditation
D. Burling; London/UK
• CAD: friend or foe?
In 2011, should CTC now be the primary
method of colorectal investigation in my
hospital?
State of the Art
Symposia
23
CT’s unrivalled
success poses
dilemmas in
thoracic emergencies
By Philip Ward
Sunday, March 6,
16:00–17:30
SF 14
Thoracic emergencies:
triage with MDCT
Should you insist that every request for an emergency CT scan is screened for its
appropriateness? Should you refuse to perform CT scans without a proper indication,
risking the anger of your referring colleagues? And how can you manage appropriateness
effectively?
There are no easy answers to these three urgent questions facing radiologists, but those
who attend the special focus session on thoracic emergencies at ECR 2011 will no doubt
be much better informed about the issues.
In many countries, imaging in the emergency department is not solely based on
appropriateness but also on defensive medicine, finances, and politics, according to session
moderator Dr. Digna R. Kool, from the department of diagnostic imaging, University
Medical Centre Nijmegen, The Netherlands, who will moderate the session. Because of fear
of missing a significant diagnosis, some clinicians request an imaging examination even
when it is in conflict with accepted clinical decision rules and evidence in the literature.
Furthermore, if CT is reimbursed fully under an insurance-based healthcare system, it will
be in the interests of the hospital – and of private practice radiologists – to perform CT.
“In many countries, politics rule, and it could be a great PR message for administrators
to stress the fact that they offer the best method to exclude potentially life-threatening
diseases, although we do not have enough evidence in this field yet,” she said.
Kool thinks all radiologists should brush up on their knowledge of acute chest pain
because the number of requests for imaging in these patients is rising fast and it is often
encountered during on-call work. Part of the increase in requests for multidetector
CT (MDCT) in acute chest pain is appropriate because technical advances have led to
significant increases in diagnostic opportunities, resulting in faster and more accurate
diagnoses and more effective clinical decision-making.
Clinicians use MDCT to decide if patients need treatment and whether they should be
admitted to hospital or can be discharged from the emergency department. Early discharge
can decrease hospital costs significantly, she stressed. However, MDCT has important
drawbacks, including costs and radiation, and with the increasing use of MDCT, the yield
in positive results is decreasing.
24
A
B
E
F
C
G
D
H
Any discussion of how to manage appropriateness in the emergency department should
consider patient selection protocols, such as clinical decision rules and research that
has been, or should be, done, Kool pointed out. Alternative diagnostic strategies, like
ventilation/perfusion lung (V/Q) scans for pulmonary embolism in young women, should
also be investigated.
MDCT is already the diagnostic reference standard for chest trauma, and allows the correct
definition of life-threatening lesions, the triage of patients, and the decision about whether
to adopt a ‘watch and wait’ approach or perform percutaneous or surgical interventions,
explained Dr. Filippo Cademartiri, a radiologist from the University of Parma in Italy. The
main drawback, however, is related to the skill of the operator in both defining the correct
technical strategy and in the interpretation of the findings.
“Patients with chest trauma are usually difficult to image because they are fairly
uncooperative, they suffer from chest pain, and their breath-hold can be hard to control,”
he commented. “Also, their heart rate, which is very important for a good MDCT
examination, is more difficult to manage in chest trauma. The latest technologies are
more robust, and they can cope with high heart rate, especially dual source CT equipment
because of its higher temporal resolution.”
To minimise radiation exposure to both patients and staff, it is necessary to consider several
factors, including the body mass index of the patient, the patient’s ability to manage breathhold and heart rate, and the presence and amount of coronary calcifications. Radiation
dose can be reduced the most when all conditions are favourable, stated Cademartiri.
Looking to the future, he anticipates a trend towards the progressive widening of the chest
CT examination performed for any indication in which the heart and coronary arteries
can be assessed.
“This translates into an inevitable screening for coronary artery disease. Radiologists are
not ready yet for this, but they should prepare,” he warned.
Finally, because newer CT technologies allow a comprehensive approach to acute chest
pain, in the near future radiologists who work in emergency departments will have to
confront the possibility of clinical requests to rule out all major causes of acute chest pain.
I
Figure:
A 73 year-old woman with
multiple cardiovascular risk
factors was admitted to the
emergency department with
chest pain radiated to the left
arm and tachycardia after blunt
trauma. ECG-gated CT of the
entire thorax was performed for
a triple rule-out. CT angiography
excluded aortic dissection and
pulmonary embolism, along
with other collateral findings. CT
showed a pattern of non-calcified,
non-obstructive atherosclerosis
along the left anterior descending
coronary artery (LAD).
A–D: volume-rendered images
of thoracic aorta and the heart
exclude aortic aneurysm and
dissection.
E: maximum intensity projection
(MIP) coronal view of right and
left pulmonary arteries without
filling defects (normal finding).
F: curved multiplanar
reconstruction (MPR) of right
coronary artery without significant
stenoses.
G, H: MPR of LAD with axial
plane. (*): concentric soft plaque
involves the bifurcation LAD –
first diagonal branch with <50%
stenosis.
I: no plaques are visible along the
left circumflex coronary artery.
(All images provided by
Dr. Filippo Cademartiri)
25
Molecular imaging
for radiologists
By Mélisande Rouger
Monday, March 7,
08:30–10:00
SF 15a
Molecular imaging
made easy
Today, most of the research done in molecular imaging is performed not by radiologists
but by scientists from other disciplines. As ultrasound, optics and MR are gaining weight
in pre-clinical imaging, it is very probable that they will soon compete with PET and
SPECT, currently the most widely used molecular imaging modalities in practices. With
this whole range of tools about to make their way into the clinic, radiologists should seize
the opportunity to be among the first to master these techniques.
A dedicated ECR 2011 session will deliver key, simple tips about the current possibilities
offered by various modalities, to spark radiologists’ interest in functional and molecular
imaging.
“Our aim is to give radiologists an introduction to molecular imaging. It should guide
them through this field by giving them useful knowledge and explaining how they can
become active in their institution,” said Fabian M.A. Kiessling, Professor of Experimental
Molecular Imaging at Aachen University Hospital, who will chair the session.
Except for a few brilliant specialists, most radiologists have limited involvement with
molecular imaging, but interest is growing. A session on the topic during the last German
Congress of Radiology attracted crowds of delegates, mainly young radiologists seemingly
keeping an eye on these tools from the very beginning of their training.
“Currently molecular imaging research is dominated by biologists, chemists and nuclear
doctors. But now that we are moving towards clinics, there is more reason for radiologists
to get closely involved. Most of them have a rough idea of what it is about. They may know
FDG PET and other PET and SPECT applications but not consider that Gd-DTPA-EOB
enhanced liver MRI, SPIO-enhanced lymph node and liver imaging, and MR-spectroscopy
are also molecular imaging applications in principle,” Kiessling said.
In particular optical imaging could be a great chance for radiologists to get started. In preclinical imaging, optics are the classical tool for examining small animals.
Successful examples of work done with optics are many, from 2008 Nobel Prize chemist
Roger Y. Tsien and his studies with GFP and RFP (fluorescent proteins) to the recent
introduction of the fluorescence camera system Xiralite , which enables diagnostic
imaging of rheumatoid arthritis in the joints of both hands.
®
26
B1
A
B2
Over the past few months, 300 to 400 cases have successfully been investigated with this
tool. As well as being reliable and relatively cheap (400,000 euros) it is also small, which
could facilitate its installation in hospitals or ambulances.
“Optical imaging will be widely used in clinics, which is why I think it’s very important to
talk about it now,” Kiessling said.
Experts will also present their work with ultrasound (US) in the imaging of angiogenesis,
cancer and plaque characterisation.
“I did a lot of molecular MRI in the past, and I am very sceptical about whether it will
broadly make its way into the clinics within the next years because it is less sensitive
than PET or optics or even US,” Kiessling said. However, molecular agents may be used
to identify healthy tissues like lymph nodes and thus delineate pathologies by their nonenhancement. In the long run, hyperpolarised agents may significantly broaden the
capability of MRI in molecular imaging.
Figure A:
Fusion image of fluorescence
optical tomography and µCT of an
atherosclerotic mouse. The colour
coding shows the activation of a
catepsin-sensitive optical probe
in an atherosclerotic plaque in the
aortic arc.
Figure B:
Accumulation of VEGFR2targeted microbubbles in highly
angiogenic (B1) and low angiogenic
(B2) breast cancer xenografts.
The high sensitivity of molecular
ultrasound imaging to characterise
angiogenesis in tumours at a
molecular level is clearly shown.
(Provided by
Dr. Fabian M.A. Kiessling)
Further developments in PET and SPECT should also encourage radiologists to acquire
skills in nuclear imaging. Its current use in clinics seems to be just the tip of the iceberg
and many more applications will be possible within a few years. Its refinement will trigger
a redefinition of diagnostic imaging, Kiessling envisions.
“Molecular imaging is already here but there is still much more potential. It should be of
big interest to the radiologist; it adds a tool to the specialisation of diagnostic radiologists.
In my opinion, the diagnostic radiologist as we know him/her now will disappear, and I
have the feeling that in the future radiologists will become universal diagnostic doctors.
They will need profound knowledge of pathologies and molecular mechanisms in order to
select how the diagnosis should be done,” he said.
However, doubts remain as to whether molecular imaging will become strong in the clinic.
Subspecialisation and training would certainly help to raise attention to the tremendous
possibilities offered by reading cellular functions. The European Institute for Biomedical
Imaging Research (EIBIR) already offers training workshops in cell imaging via its
ENCITE project. But one major aim of the ECR session is to push for the creation of
a master’s degree in molecular imaging, Kiessling underlined. “We all think that it will
change the diagnostic procedure in the future, so it is very important that radiologists are
going on with this,” he concluded.
27
Special Focus
Sessions
SF 2
Child abuse: right images,
right behaviour, right words
Friday, March 4, 08:30–10:00, Room L/M
SF 3c
Tumour response to treatment:
RECIST, desist or insist?
M.I. Argyropoulou; Ioannina/GR
R.H. Reznek; London/UK
• How to image and detect patterns of
skeletal injury indicating child abuse
P.K. Kleinman; Boston, MA/US
• Imaging strategies to fully determine
intracranial injury resulting from child abuse
C. Adamsbaum; Paris/FR
• Monitoring response to treatment in
patients with cancer: why and how.
The Oncologist’s view
P. Johnson; Southampton/UK
• What is the information required by any
court and how the radiological reports
should be phrased
S. Chapman; Birmingham/UK
• Principles in the use of conventional/anatomic imaging for response assessment
L. Schwartz; New York, NY/US
• PET in monitoring response
W. Weber; Freiburg/DE
The radiologist at the eye of the storm
Why does the radiologist need to
understand the importance of
monitoring response and how it is done?
Friday, March 4, 08:30–10:00, Room F2
SF 3a
The BI-RADS 3 controversy
M.G. Wallis; Cambridge/UK
• Defining lesions to follow-up
P. Skaane; Oslo/NO
• Decreasing the number of BI-RADS 3 in
clinical settings
L.J. Pina Insausti; Pamplona/ES
• Management of BI-RADS 3 lesions
F. Sardanelli; Milan/IT
BI-RADS 3: biopsy or watch?
Friday, March 4, 08:30–10:00, Room Q
SF 3b
The ABC of EVAR
28
M. Szczerbo-Trojanowska; Lublin/PL
• Endovascular treatment of
thoracic aortic aneurysms
J.-P. Beregi; Lille/FR
• Endovascular treatment
of abdominal aortic aneurysms
R. Morgan; London/UK
• The role of imaging in follow-up
K.A. Hausegger; Klagenfurt/AT
The key role of imaging in endovascular
aortic aneurysm repair
Friday, March 4, 08:30–10:00, Room D2
SF 3d
Head and neck oncology: the
three musketeers (CT, MR, PET)
A. Borges; Lisbon/PT
• State-of-the-art CT/MR/PET as
baseline modalities
S. Bisdas; Tübingen/DE
• State-of-the-art CT/MR/PET in
the treated neck
F.A. Pameijer; Utrecht/NL
• New techniques and protocols:
perfusion, diffusion, spectroscopy
and new PET tracers
V. Vandecaveye; Leuven/BE
The three musketeers were actually FOUR
Special Focus
Sessions
SF 6
Dynamic MR imaging of the
pelvic floor: easy and useful
D. Weishaupt; Zurich/CH
• How I do it
C.S. Reiner; Zurich/CH
• Indications and spectrum of
pathological findings
F. Maccioni; Rome/IT
• Dynamic imaging of the pelvic floor:
MR imaging or conventional technique?
Does dynamic pelvic MR imaging replace
conventional defecography?
Saturday, March 5, 08:30–10:00, Room A
SF 7
My ‘most beautiful’ mistakes
M. Zins; Paris/FR
• Abdomen
A.H. Freeman; Cambridge/UK
• GU
L.E. Derchi; Genoa/IT
• Chest
C. Schaefer-Prokop; Amersfoort/NL
Sunday, March 6, 14:00–15:30, Room F1
SF 13
Quantifying liver fat,
inflammation and fibrosis:
routine or research?
C.B. Sirlin; San Diego, CA/US
• Quantification of liver fat
S.B. Reeder; Madison, WI/US
• Quantification of liver inflammation
J.F.L. Cobbold; London/UK
• Quantification of liver fibrosis
B. Van Beers; Clichy/FR
• Summary of presentations
C.B. Sirlin; San Diego, CA/US
Routine or research?
Sunday, March 6, 16:00–17:30, Room E2
SF 14
Thoracic emergencies:
triage with MDCT
D.R. Kool; Nijmegen/NL
• MDCT in acute chest pain
F. Cademartiri; Parma/IT
What have we learned from our mistakes?
• MDCT in chest trauma:
indications, technique and interpretation
H. Mirka; Plzen/CZ
Sunday, March 6, 08:30–10:00, Room G/H
SF 11
Can we predict premature ageing?
• Radiation in emergency thoracic CT:
can it be reduced?
S. Leschka; St. Gallen/CH
Increasing use of MDCT in emergency
radiology of the chest: is it appropriate?
Can we stop it? Do we want to?
G. Guglielmi; Foggia/IT
• Brain ageing/dementia
F. Barkhof; Amsterdam/NL
• Bone and joint ageing
A. Cotten; Lille/FR
• Cardiovascular ageing
T. Saam; Munich/DE
What specific knowledge do you need to
be able to interpret and understand the
radiological scenarios in geriatric patients?
29
Special Focus
Sessions
Special Focus
Sessions
Monday, March 7, 08:30–10:00, Room E1
SF 15a Molecular imaging made easy
F.M.A. Kiessling; Aachen/DE
• Probes and targets in optical imaging
C.W.G.M. Löwik; Leiden/NL
• Ultrasound providing molecular imaging
M. Palmowski; Aachen/DE
• MR in molecular imaging
E.A. Schellenberger; Berlin/DE
Which role can radiologists easily
play in molecular imaging?
A.K. Dixon; Cambridge/UK
SF 15b CT of small airways: elementary
images for disease classification
J.A. Verschakelen; Leuven/BE
• Basic signs in small airways disease
D.M. Hansell; London/UK
• From pattern to diagnosis
C. Beigelman; Paris/FR
Monday, March 7, 16:00–17:30, Room D1
SF 18a Transarterial treatment of liver
tumours: major advances
J. Lammer; Vienna/AT
• Advances in chemoembolisation
of liver metastases
M.A. Funovics; Vienna/AT
• Embolisation of HCC with drug
eluting beads
K. Malagari; Athens/GR
• Selective internal radiotherapy
J.I. Bilbao; Pamplona/ES
• Combined therapies before and
after ablation
R. Lencioni; Pisa/IT
Which treatment option is the best for
the various stages of disease?
Monday, March 7, 16:00–17:30, Room F2
SF 18b Brain perfusion made easy:
CT/MR?
• Beyond morphology
H.-U. Kauczor; Heidelberg/DE
E.T. Tali; Ankara/TR
Signs of small airways disease can
be seen on CT but when and why
do they really matter?
• Techniques for CT and MR,
post-processing, radiation
R.A. Meuli; Lausanne/CH
• Brain tumours
A. Jackson; Manchester/UK
• Stroke and vascular diseases
J. Vymazal; Prague/CZ
Guidelines, recommendations, hints and
tips to get more from perfusion imaging
in CNS pathologies
31
New bridges could
help improve cancer
patient management
Saturday, March 5,
16:00–17:30
Joint Session of the
ESR and the EORTC
(European Organisation
for Research and
Treatment of Cancer):
PC 10
Imaging as the
number one tool for
oncology trials
The science of radiology is changing rapidly, and now offers better and more advanced tools for
imaging patients with cancer, who represent an ever increasing population. Thanks to its ability
to provide functional information on tumours, radiology has come to play a pivotal role in the
management of oncology patients. As a consequence, the role of the radiologist has continued
to expand and they have become more involved upstream in treatment.
A joint session held by the ESR and the European Organisation for Research and Treatment of
Cancer (EORTC) will present the current state of cancer imaging and explore potential areas of
collaboration that could benefit patients.
Clinicians rely more than ever on imaging studies to assess tumour response to various
treatments. While in the past the role of radiologists was often limited to measuring the
diameter and volume of tumours, nowadays multi-parametric imaging techniques allow
accurate evaluation of functional changes.
As an example, radiologists can monitor tumour blood flow through perfusion imaging
techniques; they can provide an estimate of cell density and/or nucleus/cytoplasm ratio thanks
to diffusion imaging; and they are even able to assess the ultrastructure of certain tumours
using tensor imaging, and determine tumour necrosis by using MR spectroscopy, for instance
in the brain.
With new possibilities come new responsibilities. Radiologists must not only look at and report
‘morphological’ imaging studies, but they should familiarise themselves with these new ‘multiparametric’ imaging methods.
“Many of these techniques demand a lot of work and dedication. As it is today, many radiologists
don’t have the time or the expertise in clinical trials to apply these new techniques. We will need
to train them not only to perform these imaging studies but also to learn how to interpret
functional imaging data,” said Professor Paul M. Parizel, from Antwerp University Hospital,
who will chair the session together with Françoise Meunier, EORTC Director General.
The session will provide examples of how best to assess cell density and tumour angiogenesis
through MRI. Furthermore, radiologists who attend the session will learn about the existence
of a dedicated platform for cancer research and treatment in Europe, and the role they could
play within it.
32
The EORTC is the biggest European organisation involved with clinical trials in oncology
patients. With over 300 participating institutions involved in reviewing and evaluating tumour
response, the potential it offers to radiologists is tremendous.
Parizel, who met with the EORTC in 2009, is convinced of it. “I think it is highly relevant to
work with the EORTC, and this session provides a unique opportunity for radiologists to get
involved at an early stage in the design of trials,” he said.
So far, radiologists have mainly been called upon to assess the imaging results of trials that were
often designed without their input. But the clinicians and people involved in the trials might
not have understood the full potential of radiology.
Prof. Paul M. Parizel
from Antwerp University
Hospital will co-chair the
Professional Challenges Session on
the role of imaging in oncology trials.
Dr. Françoise Meunier
is Director General of the
European Organisation for
Research and Treatment of
Cancer and will co-chair the
Professional Challenges Session.
“Radiologists are usually not directly involved in taking care of patients. The decision to
enrol some patients in certain trials is mainly made by clinicians and oncologists. As a result,
radiologists are often only involved at a later stage, when they are called upon to interpret
imaging studies. A lot of the radiological work is hidden, and, unfortunately, the public has very
little understanding of the role played by radiologists,” Parizel admitted.
And yet, in order to answer clinically relevant questions, it is important to make the correct
choices for imaging, and to tailor the imaging strategy specifically to the questions that need
to be answered.
The EORTC, which has worked a lot with nuclear medicine for PET studies for instance, lacked
structured contact with radiology. Both are now willing to improve their cooperation. “The
EORTC made the strategic decision to create an imaging group, which includes radiologists,
supported by the appropriate infrastructure, the EORTC Imaging Platform, so that we can
better face the challenge of attaining personalised medicine and targeted therapies,” explained
Meunier.
More could come out of the ECR professional challenges session.
“I hope that this session will open a window to demonstrate to radiologists that there is another
parallel universe, the one of the EORTC, and that we can build strong bridges between the two
worlds. There is no doubt in my mind that improved collaboration between the ESR and the
EORTC will open new horizons for better treatment and imaging, to the benefit of oncology
patients ,” said Parizel.
33
Professional Challenges
Sessions
Thursday, March 3, 16:00–17:30, Room L/M
Joint Session of the ESR and the EANM
(European Association of Nuclear Medicine):
PC 2
Radiology and nuclear medicine:
really a joint venture
• Chairmen’s introduction
P. Bourguet; Rennes/FR
É. Breatnach; Dublin/IE
• Evaluation of tumour response to therapy:
the role of radiology
M. O’Connell; Dublin/IE
F. Meunier; Brussels/BE
P.M. Parizel; Antwerp/BE
• Evaluation of tumour response to therapy:
the role of nuclear medicine
A. Chiti; Milan/IT
• The EORTC Imaging Group:
vision and strategy on cancer imaging
S. Stroobants; Antwerp/BE
• Alzheimer’s disease:
the role of radiology
J. Alvarez-Linera; Madrid/ES
• Can we assess cell density of tumours
with imaging techniques?
D.-M. Koh; Sutton/UK
• Alzheimer’s disease:
the role of nuclear medicine
K. Tatsch; Karlsruhe/DE
• Which imaging techniques are useful to
evaluate tumour angiogenesis?
D. Sahani; Boston, MA/US
The advantages of working together
for nuclear medicine and radiology
• Challenges for morphologic imaging in
oncology trials: reproducibility and reading
F.E. Lecouvet; Brussels/BE
Can we use imaging parameters as
biomarkers in multicentre trials and
predict tumour response?
PC 7
Professional issues in
interventional radiology:
education, training and standards
34
Joint Session of the ESR and the EORTC
(European Organisation for Research and
Treatment of Cancer):
PC 10 Imaging as the number one tool
for oncology trials
J.H. Peregrin; Prague/CZ
Monday, March 7, 08:30–10:00, Room L/M
PC 15 Teleradiology:
for better or for worse
L. Donoso; Barcelona/ES
• Education and training in IR
A.-M. Belli; London/UK
• Are we safeguarding patients’ rights?
D. Caramella; Pisa/IT
• Turf battles facing IR
J.A. Reekers; Amsterdam/NL
• Future directions in IR
M.J. Lee; Dublin/IE
• Excellence in teleradiology:
key issues in workflow management
J. Schillebeeckx; Bonheiden/BE
What does an interventional
radiologist need to know?
• Dedicated solutions for specific
clinical scenarios
H. Billing; Barcelona/ES
To what extent has teleradiology
demonstrated it can improve
radiological services?
Professional Challenges
Sessions
35
Common clinical
cases in a click
Saturday, March 5,
to Monday, March 7
CC 18
CLICK (Clinical
Lessons for Imaging
Core Knowledge):
A number of clinical situations pose severe differential diagnostic challenges to both the
radiologist and clinician. A perfect command of imaging modalities is mandatory to help
radiologists find the origin of a headache or fever, but sufficient clinical knowledge is
increasingly needed to suggest the appropriate examination, according to experts.
With clinical skills, radiologists can act as consultants in the early steps of an investigation.
They can suggest the best examination to be carried out in a patient and they must be aware
of other non-radiological examinations.
“There is an increasing need to bring about such an educational session, which combines
clinical and diagnostic imaging knowledge,” said András Palkó, Professor of Radiology
at Szeged Medical School in Hungary, who will chair a dedicated categorical course,
appropriately named Clinical Lessons for Imaging Core Knowledge (CLICK), at ECR 2011.
Six of the most common situations encountered in daily practice will be dealt with in six
dedicated sessions, each featuring a speaker focusing on clinical considerations and another
describing imaging techniques and typical findings.
In all patients, the less ionising examination will usually be carried out first. In cases of
dyspnoea, a chest x-ray is always followed by CT but there are nowadays numerous ways of
examining a patient. Here, radiologists must know to which diseases this symptom may be
linked and adapt the scanning protocol to provide the most appropriate radiation dose to
provide a diagnostic benefit to the patient.
Patient information is crucial and will influence the way the examination is carried out.
An incidentally found focal liver lesion in a patient with a known liver disease or cancer
somewhere else in his/her body will trigger a series of examinations which might prove
unnecessary in a healthy person.
36
A
B
“A combined knowledge of imaging technologies and clinicians’ expectations are key
elements for a fruitful collaboration with referring physicians, reinforcing the pivotal role
of radiologists in patients’ management,“ said Martine Rémy-Jardin, Professor of Radiology
at Hôpital Calmette in Lille, who will coordinate the session on dyspnoea
Other renowned radiologists accepted the invitation to give presentations, responding to
the challenging topic and the innovative structure.
Another particular detail might have motivated them to take part in this course. At the
end of each session, a third speaker will quiz the audience on typical cases. Equipped with
keypads, participants will have to solve each case, putting in practice what they have just
been taught.
This exercise increases the level of consciousness of the audience, Palkó believes. “It is a
kind of evaluation of the first two talks. It is a practical overview of what has been told
before; first you have the theory, then the practice,” he explained.
Interactive sessions are traditionally very popular at ECR and Palkó, who will also hold a
talk on clinical considerations in the liver, hopes to receive a positive response from the
audience. “It’s an experiment, so we’ll see. It may attract crowds of delegates but it may also
not prove quite as successful,” he said cautiously.
The ECR 2012 Programme Planning Committee, encouraged by the quality and originality
of the course, has already decided to repeat it next year.
C
Figure A:
Transverse CT scan obtained at
the level of the cardiac cavities
in a 67 year-old male smoker
presenting with progressive
worsening of dyspnoea. Note the
abnormal thinning and lipomatous
metaplasia of the left ventricular
wall (arrows), suggestive of
sequellae of myocardial infarction.
Figure B:
Transverse CT scan obtained
at the level of the upper lung
zones showing mild ground glass
attenuation, abnormal thickening
of peribronchovascular bundles,
thin septal lines and right-sided
pleural effusion. These features
are highly suggestive of interstitial
edema, thus explaining the patient’s
dyspnoea.
Figure C:
Transverse CT scan obtained below
the tracheal bifurcation showing
an endobronchial mass obstructing
the right main bronchus,
corresponding to a bronchial
carcinoid tumour.
(All images provided by
Dr. Martine Rémy-Jardin)
37
Categorical
Courses
KISS (Keep It Simple and Straightforward): Musculoskeletal MRI
Thursday, March 3, 16:00–17:30, Room D1
CC 216 The hand and wrist
Saturday, March 5, 16:00–17:30, Room D1
CC 1016The basics of MSK MRI at 3T
Moderator: R. Schmitt; Bad Neustadt a.d. Saale/DE
A. Optimising protocols
C. Glaser; Munich/DE
B. Normal variants and pitfalls
J. Hodler; Zurich/CH
B. Pitfalls, strengths and weaknesses
T.C. Mamisch; Berne/CH
C. I dentifying and reporting
abnormal findings
L. Cerezal; Santander/ES
C. New techniques and applications
S. Trattnig; Vienna/AT
CC 316 The shoulder
Moderator: A. Oktay; Izmir/TR
A. How I do it
J. Kramer; Linz/AT
M. Reijnierse; Leiden/NL
abnormal findings
S. Waldt; Munich/DE
CC 616 The knee
Moderator: J. Labuscagne; Bunbury, WA/AU A. How I do it
A. Barile; L’Aquila/IT
S.J. Eustace; Dublin/IE
abnormal findings
M. Maas; Amsterdam/NL
CC 716 The ankle and foot
Moderator: M. Shahabpour; Brussels/BE
A. How I do it
M. Zanetti; Zurich/CH
A.H. Karantanas; Iraklion/GR
abnormal findings
A. Cotten; Lille/FR
38
Moderator: A. Baur-Melnyk; Munich/DE
A. How I do it
J.-L. Drapé; Paris/FR
Sunday, March 6, 14:00–15:30, Room D1
CC 1316The lumbar spine
Moderator: M. Epermane; Riga/LV
A. How I do it
P.J. Richards; Stoke-on-Trent/UK
B. Tins; Oswestry/UK
C. Identifying and reporting
abnormal findings
A. Stäbler; Munich/DE
CC 1416Soft tissue extremity masses
Moderator: A.R. Mester; Budapest/HU
A. How I do it
J.C. Vilanova; Girona/ES
F.M.H.M. Vanhoenacker; Antwerp/BE
abnormal findings
J.L.M.A. Gielen; Edegem/BE
CC 1516The hip
Moderator: C.W.A. Pfirrmann; Zurich/CH
A. How I do it
A. Kassarjian; Majadahonda/ES
U. Studler; Basle/CH
abnormal findings
P.M. Cunningham; Navan/IE
Categorical
Courses
Radiology in Abdominal Emergencies
CC 1017Missing perfusion:
abdominal ischaemic disease
Moderator: O. Chan; London/UK
A. Mesenteric angiography: diagnostic and
therapeutic approach
B. The black bowel
P. Rogalla; Toronto, ON/CA
C. Clinical management:
what you need to know
D.E. Malone; Dublin/IE
CC 1117The hole in the guts
Moderator: S. Puri; New Delhi/IN
A. Wasting time with plain radiography?
M. Laniado; Dresden/DE
B. Defining the role of US
J.B.C.M. Puylaert; The Hague/NL
C. In search of the hole: CT
A. Laghi; Latina/IT
CC 1417Inflammation and oedema
Moderator: N. Elmas; Izmir/TR
A. The three musketeers: appendicitis,
diverticulitis, colitis
J. Stoker; Amsterdam/NL
B. Liver and biliary tree
J.A. Soto; Boston, MA/US
C. Pancreatitis: common and critical
P.R. Ros; Cleveland, OH/US
Monday, March 7, 08:30–10:00, Room A
CC 1517The acute abdomen
Moderator: J.-M. Bruel; Montpellier/FR
A. Abdominal hernias
G. Brancatelli; Palermo/IT
B. The wrong twist:
mesenteric and omental torsion
S. Efremidis; Ioannina/GR
C. Acute stages in neoplastic diseases
J.A. Guthrie; Leeds/UK
39
Categorical
Courses
CLICK (Clinical Lessons for Imaging Core Knowledge): Common Clinical Cases
40
Saturday, March 5, 08:30–10:00, Room C
CC 718 Dyspnoea
Sunday, March 6, 14:00–15:30, Room C
CC 1318Fever of unknown origin
Moderator: M. Rémy-Jardin; Lille/FR
Moderator: P.A. Grenier; Paris/FR
A. Clinical considerations
J. Neuwirth; Prague/CZ
C.P. Heussel; Heidelberg/DE
B. Imaging techniques and typical findings
H. Prosch; Vienna/AT
G.R. Ferretti; Grenoble/FR
C. I nteractive case discussion
J. Andreu; Barcelona/ES
C. Interactive case discussion
G.H. Mostbeck; Vienna/AT
CC 1018Palpable abdominal mass
CC 1418Focal neurological disorders
Moderator: F. Caseiro-Alves; Coimbra/PT
Moderator: M. Sasiadek; Wroclaw/PL
D. Akata; Ankara/TR
D. Balériaux; Brussels/BE
M. Prokop; Nijmegen/NL
P. Barsi; Budapest/HU
A.H. Freeman; Cambridge/UK
G. Krumina; Riga/LV
CC 1118Surprise in the liver
Monday, March 7, 08:30–10:00, Room C
CC 1518Female pelvic pain
Moderator: C. Bartolozzi; Pisa/IT
Moderator: A.J.M. Maubon; Limoges/FR
A. Palkó; Szeged/HU
G. Restaino; Campobasso/IT
C.J. Zech; Munich/DE
B. Brkljačić; Zagreb/HR
A.G. Rockall; London/UK
= Interactive session with electronic voting/self assessment
Categorical
Courses
41
Europe and USA
combine expertise in
oncologic imaging
Sunday, March 6,
08:30–17:30
MC 25
Joint Course of
ESR and RSNA
(Radiological Society
of North America)
Oncologic imaging is performed daily in virtually every radiology practice. Radiologists
play an essential role in detecting, characterising, and staging tumours, as well as in
assessing treatment response and monitoring for tumour recurrence.
In order to make the most of the latest important developments in cancer patient
management, radiologists need practical knowledge and up-to-date information. This is
what the two leading radiological societies, the ESR and RSNA, have planned to provide
by holding their first ever joint course at the upcoming ECR.
“Cancer is a global disease and a global challenge,” said RSNA Immediate Past President
Prof. Hedvig Hricak from New York. “This ECR/RSNA joint educational project will help
to strengthen and unify our approaches to oncologic imaging.”
Cross-sectional imaging, including CT, MRI (with its latest addition of whole body MRI)
and PET-CT, has revolutionised the way cancers are diagnosed and treated. Imaging can
now be used for many aspects of patient management, from assessment of the spread
and resistance of a tumour to monitoring of the response to therapy. In addition to basic
anatomic information, treatment monitoring now provides more and more functional
imaging parameters to assess perfusion and metabolism.
“Due to a change of paradigm regarding the treatment of oncologic patients, it has become
necessary for physicians to address the issue of oncologic imaging and education in oncologic
imaging in a worldwide vision,” said ESR Past President Prof. Christian J. Herold, from
Vienna, one of the course coordinators.
But it is also a change in the perception of oncologic imaging that prompted the idea for
a common initiative. “Oncologic imaging has been very focused for a long time, but we
feel that some sort of comprehensive approach is now necessary, because tumours are not
located in only one organ or organ system. As soon as there is a metastatic spread, they
may be distributed all across the body,” explained ESR President Prof. Maximilian F. Reiser
from Munich.
The course, which will also be held at RSNA this November, will be divided into lectures on
different tumour entities and presented by some of the finest radiologists from both sides of
the Atlantic, including Reiser and Hricak, and ECR 2011 President Prof. Yves Menu, from
Paris, with a lecture on pancreatic cancer.
42
A
D
B
C
E
These lectures will provide a practical, clinically-relevant summary of key imaging issues
in common cancers (ovarian, kidney, lymphoma, colon, pancreas, prostate and liver) using
an interactive, case-based approach. After an overview of principles of oncologic imaging
and current cancer-related terminology, there will follow organ-specific lectures focusing
on how imaging can optimise detection and characterisation of specific tumours and
measure tumour treatment response, providing a value-added radiology report.
Oncologic imaging is a wide field with a major bearing on patient health but there are
currently few opportunities for subspecialisation. This can cause uneasiness among
radiologists, experts observe.
“A large proportion of radiological practice involves imaging of cancer patients. Yet many
radiologists feel insecure when interpreting such examinations, due to a lack of specialised
training in oncologic imaging, the complexity of the findings, and the high stakes involved
for the patient,” said RSNA speaker Prof. David Panicek, from New York, who will discuss
principles of oncologic imaging and reporting.
Consequently, there are ongoing discussions regarding the introduction of oncologic
imaging as a subspecialty and its integration into the radiology curriculum.
“This joint initiative has many components: one is the course on oncologic imaging but
the additional step would be to promote oncologic imaging as a subspecialty. That would
have consequences for resident training in radiology and we are considering promoting
fellowships in oncologic imaging,” Herold said.
Could this joint course be a springboard for other common educational programmes?
“Perhaps as we work closer in education there will be opportunities in other areas
of mutual interest such as quality and safety, and research,” suggested RSNA speaker
Prof. Richard Baron, from Chicago, who will talk about liver cancers.
Other themes such as obesity, which is becoming more and more important in Europe
but already an urgent issue in the U.S., metabolic diseases such as diabetes, and radiation
exposure could be dealt with in joint sessions, said Reiser. Common forces and common
ideas would also make the societies more effective when negotiating with political decision
makers for instance, he added.
Figure A:
Complication of chemotherapy:
Chemotherapy-induced biliary
sclerosis. Contrast-enhanced CT
of a patient with biliary sclerosis
caused by hepatic arterial infusion
of fluorodeoxyuridine (FUDR)
for colorectal hepatic metastases.
Biliary sclerosis developed
three months after initiation of
treatment.
Figure B:
Prostate cancer in transition zone
with extraprostatic extension, best
shown on T2-weighted endorectal
coronal MR image. Knowledge
of tumour location facilitated a
wider anterior and lateral resection
margin than usual.
Figure C:
Preoperative CT in a patient with
stage IIIC epithelial ovarian cancer,
showing large, heterogeneous
nodal deposit in right superior
diaphragmatic region. Presence
of supra-diaphragmatic
lymphadenopathy signifies
unresectable disease and the need
for neoadjuvant chemotherapy.
Figure D, E:
Peritoneal carcinomatosis in
ovarian cancer, more evident at
T2-weighted fat-suppressed MRI
than CT. Irregular rind of tumour
is present along the posterior
surface of right hepatic lobe, just
caudal to bare area of liver. In
absence of ascites, the rind is barely
perceptible on CT.
(All images courtesy of Dept. of
Radiology, MSKCC, New York)
43
Mini
Courses
Organs from A to Z: Pancreas
Saturday, March 5, 08:30–10:00, Room B
MC 719 Imaging inflammation
and function
Moderator: O. Akhan; Ankara/TR
A. Acute pancreatitis
P.R. Ros; Cleveland, OH/US
B. Chronic pancreatitis
G. Morana; Treviso/IT
C. Management of complications of pancreatitis
C.D. Becker; Geneva/CH
• Discussion
Saturday, March 5, 16:00–17:30, Room E2
MC 1019 Cystic tumours, endocrine
neoplasms and congenital
anomalies
Moderator: I.G. Lupescu; Bucharest/RO
A. Cystic tumours
R. Pozzi-Mucelli; Verona/IT
B. Endocrine and other solid pancreatic tumours
C. Congenital and developmental anomalies
M. Karcaaltincaba; Ankara/TR
• Discussion
MC 1119Imaging adenocarcinoma
44
Moderator: T.K. Helmberger; Munich/DE
A. MDCT: how to diagnose, how to stage
W. Schima; Vienna/AT
B. MR imaging: a main course or just a side dish?
M. Zins; Paris/FR
C. Detection and staging: multimodality comparison
D.E. Malone; Dublin/IE
• Discussion
Mini
Courses
The Beauty of Basic Knowledge:
Thursday, March 3, 14:00–15:00, Room Z
MC 21A Interpreting the chest
radiograph: basic concepts
J. Cáceres; Barcelona/ES
Friday, March 4, 14:00–15:00, Room Z
MC 21B Lobar collapse
Saturday, March 5, 12:30–13:30, Room Z
MC 21C Air-space disease
Sunday, March 6, 12:30–13:30, Room Z
MC 21D Rounded lesion(s)
Monday, March 7, 12:30–13:30, Room Z
MC 21E Decreased opacity of the lung(s)
Registration:
The number of participants for each session is restricted
to 50. Participants need to register in advance as of October 1,
2010 (www.myESR.org).
45
Mini
Courses
Functional Imaging of Tumours:
How to Do It
Thursday, March 3, 16:00–17:30, Room F1
MC 222 Basics you should know
Moderator: J. Stoker; Amsterdam/NL
A. Tumour angiogenesis and perfusion parameters
D. Sahani; Boston, MA/US
B. Diffusion imaging
B.A. Taouli; New York, NY/US
C. Metabolic imaging using PET/CT
G. Antoch; Essen/DE
MC 322 Functional and ultra
structural MR
Moderator: L. Martí-Bonmatí; Valencia/ES
A. Diffusion imaging and whole body MRI
A. Luciani; Creteil/FR
B. Quality and quality control in DCE-MRI
and DCE-CT
V.J. Goh; Northwood/UK
C. Synthesis: functional imaging for tumour management
V. Vilgrain; Clichy/FR
MC 622 Dynamic contrast-enhanced
(DCE) imaging
46
Moderator: A. Ba-Ssalamah; Vienna/AT
A. DCE-CT
J. Votrubová; Prague/CZ
B. DCE-MR
A.R. Padhani; Northwood/UK
C. DCE-US
L. Solbiati; Busto Arsizio/IT
Mini
Courses
Joint Course of the ESR and RSNA
(Radiological Society of North America)
Sunday, March 6, 08:30–10:00, Room N/O
MC 1125Essentials in oncologic imaging: what
radiologists need to know (part 1)
Moderator: D.M. Panicek; New York, NY/US
A. Principles of oncologic imaging and reporting
D.M. Panicek; New York, NY/US
B. Lung cancers (primary, metastases)
C.J. Herold; Vienna/AT
C. Colon cancer
R.M. Gore; Highland Park, IL/US
• Questions
Moderator: D.M. Panicek; New York, NY/US
A. Pancreatic cancer
F. Caseiro-Alves; Coimbra/PT
B. Kidney cancer
E.K. Fishman; Baltimore, MD/US C. Ovarian cancer
H. Hricak; New York, NY/US
• Questions
Moderator: H.-U. Kauczor; Heidelberg/DE
A. Oncologic imaging: terminology, definitions and buzzwords
Y. Menu; Paris/FR
B. Liver cancers (primary, metastases)
R.L. Baron; Chicago, IL/US
C. Prostate cancer
J.O. Barentsz; Nijmegen/NL
• Questions
Moderator: H.-U. Kauczor; Heidelberg/DE
A. Lymphoma
M.P. Federle; Stanford, CA/US
B. Musculoskeletal neoplasms
M.F. Reiser; Munich/DE
C. Chemo- and radiation therapy-induced toxicity
H.-U. Kauczor; Heidelberg/DE
• Questions
47
Refresher Courses
Scientific Sessions
Thursday, March 3, 14:00–15:30, Room A
SS 101a Hepatocellular carcinoma: screening, diagnosis and management
RC 701 Tumour evaluation:
beyond morphology
Moderators: L
. Grazioli; Brescia/IT
B. Guiu; Dijon/FR
Thursday, March 3, 14:00–15:30, Room C
SS 101b Imaging of the oesophagus
and stomach
Moderators: S .A. Jackson; Plymouth/UK
A.M. Riddell; Sutton/UK
A. US and CEUS
M. Claudon; Vandoeuvre-les-Nancy/FR
B. CT and MRI perfusion
F. Berger; Munich/DE
C. MR diffusion and PET/CT
C. Della Pina; Pisa/IT
Friday, March 4, 08:30–10:00, Room C
RC 301 Abdominal lymphoma
Moderator: A. Rahmouni; Creteil/FR
A. Solid organs
E. de Kerviler; Paris/FR
B. Hollow abdominal viscera
R.M. Mendelson; Perth, WA/AU
C. G
enitourinary tract involvement
SS 401a Imaging the pancreas:
challenges and controversies
Moderators: R
.F. Dondelinger; Liège/BE
A.-S. Rangheard;
Le Kremlin Bicêtre/FR • Panel discussion:
How can you easily implement some
functional imaging into your practice?
SS 801a Imaging evaluation of liver fat,
iron and fibrosis
Moderators: J .M. Alústiza; San Sebastián/ES
M.A. Bali; Brussels/BE
SS 801b Imaging evaluation of abdominal
tumours response to therapy
Moderators: D.J. Breen; Southampton/UK
A. Siemianowicz; Piekary Slaskie/PL
SS 801c Small bowel: assessment of
function and inflammation
Friday, March 4, 10:30–12:00, Room E1
SS 401b MRI of rectal cancer
RC 1101Inflammatory bowel disease:
which test and when?
Moderators: M
. Bellomi; Milan/IT
C. Hoeffel; Reims/FR
SS 501a CT perfusion and dual energy CT
in abdominal imaging
Moderators: B
. Marincek; Kilchberg/CH
G. Petralia; Milan/IT
SS 501b CT colonography: 17 years on
48
O. Lucidarme; Paris/FR
Moderators: S . Gryspeerdt; Roeselare/BE
M.M. Morrin; Dublin/IE
Moderators: D.D.T.
Maglinte; Indianapolis, IN/US
G. Masselli; Rome/IT
Z. Tarján; Budapest/HU
A. Role of US in diagnosis and follow-up
V. Válek; Brno/CZ
B. Role of CT in diagnosis and follow-up
S. Romano; Naples/IT
C. CT versus MRI, M.A. Patak; Zurich/CH
Five good reasons for the radiologist
to be at the forefront
Refresher Courses
Scientific Sessions
Sunday, March 6, 10:30–12:00, Room A
SS 1201aDiffusion-weighted MRI:
advances and applications
RC 1501Rectal cancer imaging:
all you need to know
Moderators: S . Gourtsoyianni; Iraklion/GR
B.J. Op de Beeck; Antwerp/BE
SS 1201bColon and rectum:
a multimodality perspective
Moderators: E
. Fraile Moreno; Madrid/ES
F. Iafrate; Rome/IT
RC 1301Abdominal MRI:
protocols that work
Moderator: S.D. Yarmenitis; Iraklion/GR
A. L
iver
W. Schima; Vienna/AT
B. Small bowel and colon
N. Papanikolaou; Iraklion/GR
C. Pancreas and bile ducts
C. Matos; Brussels/BE
RC 1401CT colonography: the big picture
G. Brown; Sutton/UK
A. Staging with US and CT
A. Maier; Vienna/AT
B. Staging with MRI
L.C.O. Blomqvist; Stockholm/SE
C. Monitoring therapy and detection of
local recurrence
R.G.H. Beets-Tan; Maastricht/NL
What are the clinicians really expecting
from us: the main questions/answers
SS 1601aAdvances in MRI and US in
abdominal imaging
SS 1601bImaging of non-neoplastic
conditions of the GI tract
Moderator: S.A. Taylor; London/UK
A. O
ptimised techniques for best results
D. Regge; Turin/IT
B. Guide to interpretation and
generating a useful report
T. Mang; Vienna/AT
C. Dose, risk and relevance in
a screening population
A. Graser; Munich/DE
Moderators: S . Bohata; Brno/CZ
E. Danse; Brussels/BE
Moderators: M
.M. Maher; Cork/IE
D.J.M. Tolan; Leeds/UK
Monday, March 7, 14:00–15:30, Room N/O
SS 1701 Liver MRI approaches
function and structure
Moderators: V
. Maniatis; Athens/GR
A. Mishra; Tripoli/LY Monday, March 7, 16:00–17:30, Room C
RC 1801Peritoneum and mesentery
Moderator: F.-T. Fork: Malmö/SE
A. Primary solid peritoneal and
mesenteric tumours
M. Zins; Paris/FR
B. Imaging of cystic mesenteric or
omental masses
C. Stoupis; Maennedorf/CH
C. Patterns of peritoneal carcinomatosis
P.K. Prassopoulos; Alexandroupolis/GR
49
Refresher Courses
Scientific Sessions
Breast
SS 102 Ultrasonography: new developments
Moderators: G
.I. Kirova; Sofia/BG
F. Pediconi; Rome/IT
RC 202 Breast US
RC 1102Interventional:
from diagnosis to treatment
Moderator: G. Acunas; Istanbul/TR
A. Practical tips for a successful needle
biopsy procedure
M.T.G. Gaskarth; Cambridge/UK
B. Underestimation of disease in needle biopsies
I. Schreer; Kiel/DE
C. New developments:
therapeutic interventional procedures
B.D. Fornage; Houston, TX/US
Moderator: E. Azavedo; Stockholm/SE
A. The role of US in screening, diagnosis
and staging of breast cancer
J. Camps Herrero; Valencia/ES
B. The role of US in premalignant and benign lesions
I. Günhan-Bilgen; Izmir/TR
SS 1202 Magnetic resonance imaging
C. New technologies in US
R. Salvador; Barcelona/ES
SS 402 Mammography:
from screening to digital technology
Moderators: F
. Diekmann; Berlin/DE
G. Forrai; Budapest/HU
SS 502 Magnetic resonance imaging
Moderators: C
. de Bazelaire; Paris/FR
A. Oktay; Izmir/TR
RC 602 Breast MRI today
Moderators: U. Bick; Berlin/DE
E. Taheri; Tehran/IR
RC 1302Update in BI-RADS
Moderator: G. Forrai; Budapest/HU
A. Mammography – E. Aribal; Istanbul/TR
B. US – G. Rizzatto; Gorizia/IT
C. MRI – C.K. Kuhl; Aachen/DE
RC 1402Evaluation of the treated breast
and follow-up
W.A. Kaiser; Jena/DE
A. How to perform and interpret
high quality breast MRI
C.S. Balleyguier; Villejuif/FR
B. Evidence-based controversies
C. How to improve the specificity of breast MRI
J. Veltman; Nijmegen/NL
• Panel discussion: Do we find too many cancers with MRI?
A. Tardivon; Paris/FR
A. Evaluation of residual disease after excisional biopsy
C. Boetes; Maastricht/NL
B. Evaluation of response to neoadjuvant
chemotherapy
P.A.T. Baltzer; Jena/DE
C. Surveillance for and detection of recurrent disease after therapy
F.J. Gilbert; Aberdeen/UK
• Panel discussion: The new challenge in
breast cancer: evaluation of response
SS 1602 Biomarkers in breast MRI
Moderators: S .H. Heywang-Köbrunner; Munich/DE
C.C. Riedl; Vienna/AT
SS 1702 Current problems in breast imaging
50
Moderators: E. Belloni; Piacenza/IT
A. Kanakas; Nicosia/CY
Refresher Courses
Scientific Sessions
Cardiac
Thursday, March 3, 14:00–15:30, Room I/K
SS 103 MR imaging of coronary
artery disease
Moderators: M
. Gardarsdottir; Reykjavik/IS
A. Stadler; Vienna/AT
SS 1203Atherosclerosis imaging
Moderators: F
. Knollmann; Pittsburgh, PA/US
E. Mershina; Moscow/RU
Thursday, March 3, 16:00–17:30, Room I/K
RC 203 Cardiac imaging: what’s up Doc?
Sunday, March 6, 16:00–17:30, Room I/K
RC 1403MRI and CT before cardiac
interventions or surgery
Moderator: C. Peebles; Southampton/UK
A. 3 T cardiac imaging: twice as good?
M. Gutberlet; Leipzig/DE
B. C
ardiac CT: how low can dose go?
S. Leschka; St. Gallen/CH
G.P. Krestin; Rotterdam/NL
A. Can CT predict the outcome of
percutaneous intervention?
C. Loewe; Vienna/AT
C. C
ardiac post-processing: latest tricks
B.J. Wintersperger; Toronto, ON/CA
B. Can MRI predict the outcome of
coronary revascularisation?
M. Francone; Rome/IT
Friday, March 4, 08:30–10:00, Room I/K
RC 303 Systematic approach to
congenital heart disease (CHD)
C. The value of CT before percutaneous
aortic valve replacement
R. Salgado; Antwerp/BE
Moderator: A.P. Parkar; Bergen/NO
A. V
ascular rings and other congenital
vascular things
A.J.B.S Madureira; Porto/PT
B. M
RI: getting more specific
A.M. Taylor; London/UK
C. M
DCT: the expanding role
A. Küttner; Frankfurt a. Main/DE
SS 403a Cardiac MR:
myocardiopathies and more
Moderators: A
. Carneiro; Porto/PT
L. Natale; Rome/IT
Improve your interaction with
your colleagues
Monday, March 7, 08:30–10:00, Room I/K
RC 1503Imaging advanced stages of
ischaemic heart disease
Moderator: J.-N. Dacher; Rouen/FR
A. CT: angiography, function and perfusion
G. Feuchtner; Innsbruck/AT
B. MR perfusion imaging:
how much quantification do we need?
L. Natale; Rome/IT
C. Imaging patients after bypass surgery
K.-F. Kreitner; Mainz/DE
Friday, March 4, 10:30–12:00, Room P
SS 403b Coronary CT angiography
SS 1603Emerging techniques and applications
Moderators: H
. Alkadhi; Zurich/CH
E. Konen; Tel Hashomer/IL
SS 503 Coronary CT:
economic impact and dose issues
Moderators: D
. Fleischmann; Stanford, CA/US
D. Piotrowska-Kownacka; Warsaw/PL
Moderators: G
. Hadjidekov; Sofia/BG
P.K. Vanhoenacker; Aalst/BE
SS 1703Valvular and congenital heart disease
Moderators: G
. Bastarrika; Pamplona/ES
G.K. Schneider; Homburg a.d.
Saar/DE
SS 803 Cardiac stress imaging
and functional analysis
Moderators: S . Katsilouli; Athens/GR
F. Pugliese; London/UK
51
Refresher Courses
Scientific Sessions
Chest
SS 104 Lung cancer imaging
Moderators: A
. Devaraj; Cambridge/UK
J.D. Dodd; Dublin/IE
SS 404 Pulmonary nodules:
detection and characterisation
Moderators: E
. Rizzo; Genolier/CH
M. Scaglione; Castel Volturno/IT Friday, March 4, 14:00–15:30, Room D1
SS 504 Diffuse lung disease
Moderators: D
. Hahn; Würzburg/DE
N. Sverzellati; Parma/IT
RC 604 Bedside chest imaging
Moderator: H. Prosch; Vienna/AT
A. Bedside chest radiography: technical
aspects and correct interpretation
E. Eisenhuber; Vienna/AT
B. Bedside thoracic ultrasonography:
how far can it go?
K. Vidmar Kocijancic; Ljubljana/SI
C. R
adiologic-guided bedside interventions
of the thorax
F. Gleeson; Oxford/UK
Saturday, March 5, 08:30–10:00, Room I/K
RC 704 Non-small cell lung cancer
Moderator: J. Vilar; Valencia/ES
A. Update in TNM classification
S. Diederich; Düsseldorf/DE
B. PET/CT in lung cancer
N. Howarth; Chêne-Bougeries/CH
C. R
adiofrequency ablation of NSCLC:
current status
F. Deschamps; Villejuif/FR
52
RC 1004Diffuse lung diseases:
what the radiologist should know
A. The glossary of terms for thoracic
imaging: old and new definitions
J.A. Verschakelen; Leuven/BE
B. From pattern recognition to disease
diagnosis: a practical approach (part 1)
M.-L. Storto; Chieti/IT
C. From pattern recognition to disease
diagnosis: a practical approach (part 2)
T. Franquet; Barcelona/ES
how do we report CT of the chest?
RC 1104CT angiography of the chest
beyond aorta
Moderator: C. Engelke; Göttingen/DE
A. CT angiography for PE diagnosis during
pregnancy and post-partum
M.-P. Revel; Paris/FR
B. CT angiography of large vessel vasculitis
A.A. Bankier; Boston, MA/US
C. CT angiography for severe haemoptysis
A.R. Larici; Rome/IT
RC 1304When CT sees both the heart and
the lungs
L. Bonomo; Rome/IT
A. Anatomic cardiac details that every
radiologist should know
S.P.G. Padley; London/UK
B. Incidental findings and their
clinical relevance
A. de Roos; Leiden/NL
SS 804 Pulmonary embolism and beyond
C. Pulmonary hypertension and
right ventricle function
M. Rémy-Jardin; Lille/FR
Ready for routine reporting of cardiovascular findings on CT scans of the chest?
Moderators: D
. Musset; Clamart/FR
G. Staskiewicz; Lublin/PL
Refresher Courses
Scientific Sessions
Chest
SS 1604 Pulmonary infection
and cystic fibrosis
Moderators: I . Hartmann; Rotterdam/NL
G.H. Mostbeck; Vienna/AT
SS 1704 CT angiography of the chest:
dual energy and beyond
Moderators: N
. Tacelli; Lille/FR
E.J.R. van Beek; Edinburgh/UK
RC 1804The new faces of pulmonary
infection
Moderator: B. Feragalli; Chieti/IT
A. Aspergillosis in the
immunocompromised patient
S.J. Copley; London/UK
B. The changing patterns of
pulmonary tuberculosis
W.F.M. De Wever; Leuven/BE
C. Emerging viral infections
53
Refresher Courses
Scientific Sessions
Thursday, March 3, 14:00–15:30, Room Q
SS 105 CAD, image analysis
Moderators: P
. Badura; Gliwice/PL
P. Mildenberger; Mainz/DE
Thursday, March 3, 16:00–17:30, Room Q
RC 205 Computer-aided detection/diagnosis
• C
hairman’s introduction
E. Pietka; Gliwice/PL
A. The role of CAD in modern-day imaging
A. Todd-Pokropek; London/UK
B. Emergence of open-source software
O. Ratib; Geneva/CH
C. CAD in oncology: from principles to
clinical implementation
E. Neri; Pisa/IT
• P
anel discussion:
The take-home points
SS 1605Image analysis in oncology
Moderators: M
. Onu; Bucharest/RO
J. Reponen; Raahe/FI
Monday, March 7, 14:00–15:30, Room Q
SS 1705Managing patient dose,
quality assurance
Moderators: E
. Bellon; Leuven/BE
J. Fernandez-Bayó; Sabadell/ES
RC 1805Image sharing
• C
A. Image data beyond radiology:
new techniques
E.R. Ranschaert; ’s-Hertogenbosch/NL
B. Intraoperative imaging for surgeons
A. Pietrabissa; Pisa/IT
C. Images and models for CAS
H.U. Lemke; Berlin/DE
54
• P
anel discussion:
The take-home points
Refresher Courses
Scientific Sessions
Molecular Imaging and Contrast Media
Thursday, March 3, 14:00–15:30, Room N/O
SS 106 PET CT as a tool for
molecular imaging
Moderators: A
. Hauser; Bruderholz/CH
M. Schwaiger; Munich/DE
Friday, March 4, 16:00–17:30, Room N/O
RC 606 Clinical potential of
molecular imaging:
between dream and reality
Moderator: G. Frija; Paris/FR
A. Molecular imaging from bench to bedside
F.M.A. Kiessling; Aachen/DE
RC 306 Contrast media:
always as safe as we wish?
B. Cardiovascular disease
L. Hofstra; Utrecht/NL
• C
S.K. Morcos; Sheffield/UK
C. Oncology
M.G. Pomper; Baltimore, MD/US
A. Iodinated CM: whether CIN is a SIN,
and how to avoid it
R.W.F. Geenen; Alkmaar/NL
B. MR contrast agents: rumble in the jungle
G. Heinz-Peer; Vienna/AT
C. PET tracers: established tracers and
those on the horizon
F.C. Gärtner; Munich/DE
• Panel
discussion:
What specific precautions are mandatory
in order to guarantee contrast media safety
to patients and healthcare professionals?
SS 1206MRI as a tool for
molecular imaging
Moderators: A
. Rahmouni; Creteil/FR
W. Semmler; Heidelberg/DE
SS 1606Contrast media:
clinical evidence, news and facts
Moderators: T
. Leiner; Utrecht/NL
B. Tombach; Osnabrück/DE
SS 406 Breaking news on MR contrast
media: from cell specificity to
clinical safety
SS 1706Fancy new stuff in experimental
and clinical molecular imaging
Moderators: T
. Allkemper; Münster/DE
A. Giovagnoni; Ancona/IT
Moderators: C.D. Claussen; Tübingen/DE
M.G. Pomper; Baltimore, MD/US
55
Refresher Courses
Scientific Sessions
Genitourinary
SS 107 Gynaecologic masses
SS 1207Renal MRI
Moderators: C.D. Alt; Heidelberg/DE
K. Kinkel; Chêne-Bougeries/CH
RC 307 Gynaecologic emergency and
its mimics
RC 1307Kidney: imaging and intervention
A. Angiomyolipoma: a review
N. Grenier; Bordeaux/FR
Moderator: K. Kinkel; Chêne-Bougeries/CH
A. Imaging of emergencies in pregnancy
G. Masselli; Rome/IT
B. Emergencies of gynaecologic origin
A.G. Rockall; London/UK
C. E
mergencies of non-gynaecologic origin
D. Akata; Ankara/TR
SS 507 Prostate cancer
Moderators: U
.G. Mueller-Lisse; Munich/DE
M. Secil; Izmir/TR
RC 707 CTU and MRU:
urinary tract imaging
Moderator: R. Manfredi; Verona/IT
A. CTU/MRU in acute obstruction
T. Meindl; Munich/DE
B. Chronic/intermittent obstruction
M.-F. Bellin; Le Kremlin-Bicêtre/FR
RC 1007Imaging of the scrotum and penis
Moderator: S.S. Ozbek; Izmir/TR
A. Acute scrotum
B. Brkljačić; Zagreb/HR
B. Scrotal tumours
L.E. Derchi; Genoa/IT
C. I maging of the penis
M. Bertolotto; Trieste/IT
Moderator: M.N. Özmen; Ankara/TR
B. The (not so) rare malignant tumours of
the kidney
P. Hallscheidt; Heidelberg/DE
C. Radiofrequency and cryotherapy of
renal tumours: techniques, results
and complications
J.-M. Correas; Paris/FR
RC 1407MRI in prostate cancer
J. Venancio; Lisbon/PT
A. MRI in detection of prostatic cancer
F. Cornud; Paris/FR
B. MRI in the post-treatment follow-up
A.T. Turgut; Ankara/TR
C. New frontiers in imaging of the prostate
J.O. Barentsz; Nijmegen/NL
C. T
umours: CTU/MRU
N.C. Cowan; Oxford/UK
56
Moderators: O
. Buckley; Dublin/IE
S. Moussa; Edinburgh/UK
What is the most appropriate
radiological approach in patients
with rising PSA levels, and when?
SS 1607Male lower urinary tract
Moderators: D
. Beyersdorff; Berlin/DE
O. Nikolic; Novi Sad/RS
SS 1707Recent advances in GU
Moderators: G
. Ivanac; Zagreb/HR
R.H. Oyen; Leuven/BE
Refresher Courses
Scientific Sessions
Head and Neck
Thursday, March 3, 14:00–15:30, Room G/H
SS 108 Ear, eye and paranasal sinuses
Moderators: N
. Dfouni; Geneva/CH
K. Zelenak; Martin/SK
Thursday, March 3, 16:00–17:30, Room N/O
RC 208 An insight into middle ear
pathologies
Moderator: T.J. Vogl; Frankfurt a. Main/DE
A. N
ormal anatomy and congenital
malformations of the middle ear
C. Czerny; Vienna/AT
B. Cholesteatoma and chronic infection
F. Veillon; Strasbourg/FR
C. Implants and postoperative findings in
the middle ear
B. Verbist; Leiden and Nijmegen/NL
SS 408 Challenges in head and neck cancer
Moderators: M
.I. Furmanek; Warsaw/PL
H.C. Thoeny; Berne/CH
Saturday, March 5, 08:30–10:00, Room N/O
RC 708 Suprahyoid neck
Moderator: D. Pereira Coutinho; Lisbon/PT
A. A
natomy-guided differential diagnoses
C.R. Habermann; Hamburg/DE
B. S uprahyoid neck lesions in daily clinical
practice
V. Chong; Singapore/SG
C. Tips and tricks for suprahyoid neck lesions
A. Trojanowska; Lublin/PL
RC 1008Runny and stuffy noses:
paranasal sinus imaging
RC 1508Common pains
in the head and neck
Moderator: K. Hrabák; Budapest/HU
A. Salivary colic
T. Beale; London/UK
B. Trigeminal neuralgia
B.F. Schuknecht; Zurich/CH
C. Painful swallowing
M. Becker; Geneva/CH
Monday, March 7, 14:00–15:30, Room G/H
SS 1708Insights into thyroid and
parathyroid pathologies
Moderators: L. Grzycka-Kowalczyk; Lublin/PL
J. Olliff; Birmingham/UK
RC 1808Management of the
post-treatment head and neck:
a diagnostic dilemma
R. Maroldi; Brescia/IT
A. Expected changes after treatment
R. Hermans; Leuven/BE
B. Surveillance imaging, tumour recurrence
and treatment complications
A.D. King; Hong Kong/CN
C. Predicting outcome after radiation
therapy in head and neck cancer:
what is evidence-based?
R. Maroldi; Brescia/IT
Recurrence, inflammation, necrosis or
scar: is imaging useful?
• C
M.G. Mack; Frankfurt a. Main/DE
A. F
unctional anatomy and
anatomic variants
S. Robinson; Vienna/AT
B. S inusitis: imaging findings before
and after treatment
D. Farina; Brescia/IT
C. S inonasal tumours
H.B. Eggesbø; Oslo/NO
Diagnostic considerations in runny
and stuffy noses
57
Refresher Courses
Scientific Sessions
SS 109 Interventional oncology
RC 1109Venous intervention
Moderator: L. Lonn; Copenhagen/DK
A. DVT and prevention of pulmonary emboli
C. Binkert; Winterthur/CH
B. Endovascular treatment of varicose veins
D.J. West; Stoke-on-Trent/UK
C. Central venous occlusions
C. Hohl; Siegburg/DE
Moderators: L
. Crocetti; Pisa/IT
S.K. Venkatesh; Singapore/SG
RC 209 The trauma patient
A. Nicholson; Leeds/UK
A. Imaging modalities and logistics
J. Ferda; Plzen/CZ
B. Management of arterial trauma
M. Katoh; Homburg/DE
SS 1209Musculoskeletal intervention
C. Solid organ trauma
J. Cazejust; Paris/FR
• Panel discussion: Do we need IR in the ER?
SS 409 Chemoembolisation of
liver tumours
RC 1309Infection and percutaneous
drainage
Moderator: M. Bezzi; Rome/IT
A. Empyema
A. Keeling; Dublin/IE
SS 509 US, MR and CT guided
interventions
B. Abdominal abscess
V. Válek; Brno/CZ
C. Pelvic abscess
M.A. Funovics; Vienna/AT
RC 1409Oncologic interventions
in the liver
Moderators: N
. Fotiadis; London/UK
J. Tacke; Passau/DE
Moderators: G
. Goh; London/UK
R.W. Günther; Aachen/DE
RC 609 RF ablation beyond the liver
Moderator: M. Glynos; Athens/GR
A. RF ablation
Moderator: A. Adam; London/UK
A. RF ablation in bone
A.D. Kelekis; Athens/GR
B. RF ablation in the kidney
M.A. Farrell; Waterford/IE
B. Portal embolisation
O.M. van Delden; Amsterdam/NL
C. RF ablation in the chest
I. Bargellini; Pisa/IT
C. Future directions
J. Kettenbach; Berne/CH
SS 809 Peripheral vascular intervention
58
Moderators: X. Buy; Strasbourg/FR
T. Sikdar; Harlow/UK
Moderators: M
. Cerna; Olomouc/CZ
G.N. Papageorgiou; Athens/GR
Refresher Courses
Scientific Sessions
RC 1509Musculoskeletal interventions
A. Gangi; Strasbourg/FR
A. Guidelines for spinal infiltrations and
nerve blocks
S. Masala; Rome/IT
B. Vertebroplasty and kyphoplasty
T. Sabharwal; London/UK
C. Interventional management of painful
osseous metastases
A.G. Ryan; Waterford City/IE
Experience-based vs evidence-based
practice in spinal intervention
SS 1609Aorta, vein and lymphatic
interventions
Moderators: S. Müller-Hülsbeck; Flensburg/DE
J. Raupach; Hradec Kralove/CZ
SS 1709Genitourinary and
gastrointestinal interventions
Moderators: S.A. Thurnher; Vienna/AT
M.A.A.J. van den Bosch; Utrecht/NL
59
Refresher Courses
Scientific Sessions
Musculoskeletal
SS 110 Tumours, bone marrow and
whole body
Moderators: M
. Adriaensen; Heerlen/NL
J.F.M. Meaney; Dublin/IE Friday, March 4, 10:30–12:00, Room F1
SS 410 Cartilage and bone imaging
Moderators: G
. Andreisek; Zurich/CH
A. Blum; Nancy/FR
Friday, March 4, 14:00–15:30, Room B
SS 510 Spine
Moderators: M.P. Aparisi Gomez; Valencia/ES
V.N. Cassar-Pullicino; Oswestry/UK
RC 610 Metabolic bone diseases
Moderator: J. Freyschmidt; Bremen/DE
A. Metabolic bone disease for the
practicing radiologist
M. Sundaram; Cleveland, OH/US
B. Latest advance in osteoporosis
C.R. Krestan; Vienna/AT
C. R
ickets, osteomalacia, hyperparathyroidism and renal osteodystrophy
J.E. Adams; Manchester/UK
RC 710 Bone marrow oedema and bone
marrow oedema-like lesions
• C
B. Vande Berg; Brussels/BE
A. BME and osteoarthritis
F.W. Roemer; Augsburg/DE
B. BME and early inflammatory disease
A.J. Grainger; Leeds/UK
C. BME and trauma
O. Hauger; Bordeaux/FR
• P
anel discussion:
Can we still use the term BME
or should we be more specific?
SS 810 Hip and ankle
Moderators: A. Feydy; Paris/FR
V. Zubler; Zurich/CH
RC 1010Hip through the ages
Moderator: E.C. Kavanagh; Dublin/IE
A. The paediatric hip
D.J. Wilson; Oxford/UK
B. The hip in the young athlete
C.W.A. Pfirrmann; Zurich/CH
C. The ageing hip
A.H. Karantanas; Iraklion/GR
RC 1110Sports injuries: US or MRI?
G.M. Allen; Oxford/UK
A. Muscle and US
C. Martinoli; Genoa/IT
B. Tendon and US
A. Klauser; Innsbruck/AT
C. Muscle and tendon by MRI
U. Aydingoz; Ankara/TR
• Panel Discussion:
What is the best imaging modality for
diagnosing sports injuries?
SS 1210Shoulder and wrist
Moderators: I.W. McCall; Oswestry/UK
S.P. Morozov; Moscow/RU
RC 1310Postoperative imaging of the
lower extremity
Moderator: F. Aparisi; Valencia/ES
A. Hip
S.J. Eustace; Dublin/IE
B. Knee
K. Verstraete; Gent/BE
C. Ankle
C. Masciocchi; L’Aquila/IT
60
Refresher Courses
Scientific Sessions
Musculoskeletal
SS 1610Inflammation and infection
Moderators: G. Mantzikopoulos; Athens/GR
M.C. Wick; Innsbruck/AT
SS 1710aMusculoskeletal intervention
Moderators: J. Martel; Alcorcón/ES
C. van Rijswijk; Leiden/NL
SS 1710bImaging the knee
Moderators: A. Platkajis; Riga/LV
R.M. Rodrigo; Bilbao/ES
RC 1810Bone tumours
J.L. Bloem; Leiden/NL
A. Diagnosis: from radiographs to MRI
K. Wörtler; Munich/DE
B. Staging and intervention
S. James; Birmingham/UK
C. New techniques (including DWI)
S. Pans; Leuven/BE
What is the clinical impact of advanced
imaging, and when should what kind of
advanced/sophisticated imaging be used?
61
Insights into Imaging
Education and strategies in European radiology
Learn to see things differently
The ESR’s new bi-monthly journal offers a whole new perspective on European
radiology, uncovering trends, revealing policy statements and taking a deeper look
into the issues that surround radiological practice. For a real insight into the world
of imaging, visit www.i3-journal.org
Refresher Courses
Scientific Sessions
Neuro
Thursday, March 3, 14:00–15:30, Room L/M
SS 111 Brain tumours:
grading, treatment and follow-up
Saturday, March 5, 16:00–17:30, Room G/H
RC 1011Common disorders of the
paediatric brain
Moderator: O. Flodmark; Stockholm/SE
A. Foetal MR imaging: more than just
T2-weighted images
C. Hoffmann; Tel Hashomer/IL
B. Normal findings and pitfalls in paediatric neuroimaging
A. Rossi; Genoa/IT
C. Neuroimaging in the acutely ill child
E. Vázquez; Barcelona/ES
Moderators: D. Goldsher; Haifa/IL
A. Levinsson; Malmö/SE
Thursday, March 3, 16:00–17:30, Room G/H
RC 211 Introduction to the brain
Moderator: T. Stosic-Opincal; Belgrade/RS
A. Brain anatomy made easy
T.A. Yousry; London/UK
B. Pattern recognition and normal variants to know
M.M. Thurnher; Vienna/AT
RC 1111Imaging stroke
C. Clinical symptoms correlated to brain anatomy
M. Smits; Rotterdam/NL
R. Siemund; Lund/SE
SS 411 Brain tumours:
detection and characterisation
A. Etiology and pathophysiology of stroke
R. von Kummer; Dresden/DE
B. Stroke imaging in the acute phase or in
critically ill patients
C. Intervention in stroke
M. Leonardi; Bologna/IT
• Panel discussion: Where do we stand in stroke therapy
today?
Moderators: P
. Demaerel; Leuven/BE
P. Zamecnik; Heidelberg/DE
SS 511a Imaging in stroke
Moderators: J. Fiehler; Hamburg/DE
J. Frühwald-Pallamar; Vienna/AT
SS 511b Neurovascular diseases
Moderators: I .Q. Grunwald; Oxford/UK
A. van der Lugt; Rotterdam/NL
SS 811 Neurovascular intervention
planning and follow-up
Moderators: S .J. Bakke; Oslo/NO
S. Puchner; Vienna/AT
SS 1211 Added value of DTI and fMRI
in brain and spine
Moderators: A. Bizzi; Milan/IT
D. Seixas; Vila Nova de Gaia/PT
RC 1311Focal brain lesions
Moderator: M. Golebiowski; Warsaw/PL
A. Differential diagnosis of T2 hyperintense lesions
A. Rovira-Cañellas; Barcelona/ES
B. Neoplasm or non-neoplasm
Z. Rumboldt; Charleston, SC/US
C. Adult glioma: advanced neuroimaging
for treatment planning
C. Calli; Izmir/TR
63
Refresher Courses
Scientific Sessions
Neuro
RC 1411Update on brain aneurysms
• Chairman’s introduction to brain aneurysms
S. Bracard; Nancy/FR
A. Subarachnoid haemorrhage
L. van den Hauwe; Brasschaat/BE
B. CTA/MRA in aneurysm diagnosis
Z. Merhemic; Sarajevo/BA
C. Treatment of aneurysms 2011
P. Vilela; Almada/PT
• Panel discussion: Where do we stand in brain aneurysm
treatment today?
RC 1511Epilepsy
B. Gómez-Ansón; Barcelona/ES
A. Tumour as a cause of epilepsy
M. Stajgis; Poznan/PL
B. Non-neoplastic causes of epilepsy
M.A. Papathanasiou; Athens/GR
C. Multimodality epilepsy protocol
L. Stenberg; Lund/SE
• Panel discussion: Imaging epilepsy?
SS 1611 Imaging applications, software
and post-processing
Moderators: N
. Bargalló; Barcelona/ES
A. Löve; Lund/SE
SS 1711 Paediatric neuroimaging:
from fetus to child
Moderators: I.M. Björkman-Burtscher; Lund/SE
G. Morana; Genoa/IT
RC 1811Spinal cord
Moderator: M. Muto; Naples/IT
A. Myelitis vs myelopathy
M. Gallucci; L’Aquila/IT
B. Spinal intradural tumours
J.W.M. Van Goethem; Antwerp/BE
C. Vascular disorders of the spinal cord
R. Nijenhuis; Maastricht/NL
Refresher Courses
Scientific Sessions
Paediatric
Saturday, March 5, 08:30–10:00, Room Q
RC 712 Advanced brain imaging
Sunday, March 6, 16:00–17:30, Room Q
RC 1412Children’s bones and joints
Moderator: C. Venstermans; Antwerp/BE
Moderator: M. Rasero; Madrid/ES
A. Diffusion tensor MRI
A. Righini; Milan/IT
B. MR spectroscopy
L. Astrakas; Ioannina/GR
A. Imaging findings in childhood osteomyelitis
R.R. van Rijn; Amsterdam/NL
C. Vascular diseases: the role of CTA, MRA, angiography (DSA)
N. Girard; Marseille/FR
B. Hip dysplasia: US techniques and recommendations
K. Rosendahl; Bergen/NO
C. Whole body imaging: PET/CT vs MRI
P.D. Humphries; London/UK
SS 812 Neuroradiology: pre- and
postnatal studies
Moderators: C. Roche; Galway/IE
L. Tzarouchi; Ioannina/GR
RC 1112Abdominal emergencies in children
RC 1512Chest imaging:
what to use and when to use it
Moderator: M. Raissaki; Iraklion/GR
A. Thoracic trauma and foreign body inhalation
M.L. Lobo; Lisbon/PT
Moderator: M. Haliloglu; Ankara/TR
A. Non-traumatic acute abdomen
C. Veyrac; Montpellier/FR
B. Infiltrative diseases of the chest
G. Staatz; Mainz/DE
B. GU emergencies in children: kidney, ovary, testis
M. Riccabona; Graz/AT
C. MRI of the chest in children
M.U. Puderbach; Heidelberg/DE
C. Abdominal trauma in children
M.P. García-Peña; Barcelona/ES
SS 1612 Abdominal and malignant diseases
Moderators: C. Balassy; Vienna/AT
L.-S. Ording-Müller; Tromsø/NO
SS 1212 Cardiothoracic imaging
Moderators: A.D. Calder; London/UK
M.A. Lucic; Sremska Kamenica/RS
RC 1312Safety first
Moderator: R. Fotter; Graz/AT
A. Security and dose with conventional
radiology
J.-F. Chateil; Bordeaux/FR
B. CT in children: dose reduction strategies
R.A.J. Nievelstein; Utrecht/NL
C. Ensuring safety for infants undergoing MRI
T.G. Maris; Iraklion/GR
65
Refresher Courses
Scientific Sessions
SS 513 New CT reconstruction and
post processing techniques
Sunday, March 6, 14:00–15:30, Room P
RC 1313Clinical audit, accreditation and
the role of the medical physicist
Moderators: J. Damilakis; Iraklion/GR
C. Leidecker; Forchheim/DE
Saturday, March 5, 16:00–17:30, Room P
RC 1013Diagnostic radiology
and pregnancy
Moderators: R
. Padovani; Udine/IT
H. Ringertz; Linköping/SE
A. Conceptus doses and risks from maternal
diagnostic x-ray examinations
J. Damilakis; Iraklion/GR
B. X-ray imaging and pregnancy: justification and optimisation of exposure
P. Vock; Berne/CH
Moderators: W.J.M. van der Putten; Galway/IE
M. Wucherer; Nürnberg/DE
A. European-wide perspective on clinical audit
H. Jarvinen; Helsinki/FI
B. National perspective: clinical audit inspections
S. Ebdon-Jackson; Didcot/UK
C. Hospital perspective on clinical audit
P. Gilligan; Dublin/IE
RC 1413Visualisation, perception and
image processing
Moderators: A.A. Lammertsma; Amsterdam/NL
B.B. Wein; Aachen/DE
A. Visualisation and perception
A.G. Gale; Loughborough/UK
B. Image processing and perception
B.M. ter Haar Romeny; Eindhoven/NL
C. Clinical application of image processing
A. Persson; Linköping/SE
C. Pregnancy and MRI: risks to the unborn child
J. De Wilde; Edinburgh/UK
RC 1113High field MRI: beyond 3T
Moderators: M
. Tosetti; Pisa/IT
A.J. van der Molen; Leiden/NL
A. Challenges of high field MR
M. Bock; Heidelberg/DE
Monday, March 7, 08:30–10:00, Room P
RC 1513Simulations make us understand
x-ray imaging
B. A complicated solution to a complicated
problem: transmit array
K.P. Pruessmann; Zurich/CH
C. Is 7T ready for clinical use?
R.W. Bowtell; Nottingham/UK
SS 1213 Novel techniques and
new technologies
Moderators: L. Struelens; Mol/BE
A. Todd-Pokropek; London/UK
Moderators: K. Bacher; Gent/BE
S. Barter; Cambridge/UK
A. Monte Carlo simulations of x-ray tubes
and x-ray spectra
M. Koutalonis; London/UK
B. Monte Carlo simulations of virtual patients (anthropomorphic phantoms)
P.R. Bakic; Philadelphia, PA/US
C. Monte Carlo simulations of x-ray detectors and x-ray images
K. Smans; Leuven/BE
SS 1613 X-ray technologies:
assessment, QA and dosimetry
Moderators: R. Grimmer; Erlangen/DE
U. Zdesar; Ljubljana/SI
SS 1713 Technical validation of the new
opportunities in CT imaging
66
Moderators: J. Geleijns; Leiden/NL
W. Stiller; Heidelberg/DE
Refresher Courses
Scientific Sessions
Radiographers
Saturday, March 5, 08:30–10:00, Room L/M
RC 714 Radiography as a profession
and a science
Sunday, March 6, 10:30–12:00, Room L/M
SS 1214 The radiographer‘s role in
optimising radiation exposure
Moderators: N
. Kinsman; Poole/UK
C. van Kuijk; Amsterdam/NL
A. Cultural competence in the practice of
radiography: international implications
N.N.
B. Basic technique for image interpretation
C. Patrick; Poole/UK
SS 814 Improving productivity and quality:
the radiographer‘s area of responsibility
Moderators: B. Bjorkman; Huskvarna/SE
D. Tscholakoff; Vienna/AT
RC 1014Radiography as an
ethical practice
Moderators: B
.T. Andersson; Lund/SE
A.L. Baert; Kessel-Lo/BE
A. The relationship between man and technology in radiographic practice: a narrative approach
B.R. Mussmann; Odense/DK
B. Ethical codes across Europe
D.S. Oreti; Monfalcone/IT
C. Ethical problems in diagnostic radiology
in terms of radiation protection
K. Paalimäki-Paakki; Oulu/FI
RC 1114Radiation protection and optimisation of radiological procedures
Moderators: K
. Åhlström Riklund; Umea/SE
D. Katsifarakis; Athens/GR
A. Diagnostic quality and patient dose
management in digital radiography systems
L.J.O.C. Lanca; Lisbon/PT
B. The radiographer’s position in the initial
optimisation procedure
D. Pekarovic; Ljubljana/SI
C. Radiation dose optimisation and the
radiographer’s role
A. Henner; Oulu/FI
Moderators: M. Maas; Amsterdam/NL
G. Paulo; Coimbra/PT
RC 1314Radiotherapy and integration with
a diagnostic-therapeutic path
Moderators: S . Geers-van Gemeren; Utrecht/NL
C. Hohl; Siegburg/DE
A. Electronic portal imaging used for development and improvements in radiation therapy for prostate cancer
A. Thorolfsdottir; Reykjavik/IS
B. Image-guided radiation therapy: when imaging meets therapy
A. Sarchosoglou; Athens/GR
C. Bridges between radiotherapy and radiography from a European perspective
K. Sjövall; Lund/SE
RC 1414Radiography in the
operating theatre
Moderators: R
. Passariello; Rome/IT
A. Yule; Cardiff/UK
A. Cone-beam CT imaging in the operating
room during endovascular aortic repair
(EVAR)
K.R. Eide; Trondheim/NO
B. Key radiographic skills in the operating theatre
K.G. Holmes; Lancaster/UK
67
Refresher Courses
Scientific Sessions
Vascular
SS 115 Aorta
Moderators: E. Bruguiere; Paris/FR
T. Pfammatter; Zurich/CH
Thursday, March 3, 16:00–17:30, Room P
RC 215 Extracranial vascular
malformations: imaging strategies
prior to endovascular therapy
J.E. Jackson; London/UK
A. Pathology, correct anatomical classification and clinical work-up
H. Kubiena; Vienna/AT
B. Imaging of capillary, venous, lymphovenous and arteriovenous malformations
L. Schultze Kool; Nijmegen/NL
C. Technical aspects of endovascular treatment
P.C. Rowlands; Liverpool/UK
• Panel discussion: Who should decide management?
SS 415 Neurovascular disorders
Moderators: G. Markose; London/UK
L.N. Tanenbaum; New York, NY/US
SS 515 Peripheral arteries
Moderators: F. Fanelli; Rome/IT
V. Sarajlic; Sarajevo/BA
RC 615 Non-traumatic acute aortic dissection and malperfusion syndromes
68
A. Predisposing factors for developing non-traumatic acute aortic dissections
V. Bérczi; Budapest/HU
B. Acute aortic dissections: detection and classification
C. Acute aortic dissections: imaging of complications
M.H.K. Hoffmann; Ulm/DE
• Panel discussion: Which imaging modality is best for
endovascular management?
RC 715 Vascular imaging: diabetes and
vascular occlusive disease
Moderator: M. Sapoval; Paris/FR
A. Metabolic syndrome, diabetes and vascular disease: what do we need to know?
E. Minar; Vienna/AT
B. Imaging strategies in the diabetic
foot syndrome
R. Iezzi; Rome/IT
C. Imaging prior to revascularisation: CTA, MRA or DSA?
S.O. Schönberg; Mannheim/DE
SS 815 Vessel wall, plaque, diabetes
Moderators: I.E. Chemelli-Steingruber;
Innsbruck/AT
A. Cieszanowski; Warsaw/PL
SS 1615 Special applications,
functional imaging
Moderators: W.P.T.M. Mali; Utrecht/NL
M. Sadick; Mannheim/DE
RC 1815Advances in vascular imaging
Moderator: P.M.T. Pattynama; Gouda/NL
A. Vascular imaging at 3T
H. Hoppe; Berne/CH
B. Dual energy CT and time resolved CT
K. Nikolaou; Munich/DE
C. Flat panel CT (C-arm CT)
H. Rousseau; Toulouse/FR
EFOMP
Workshop
New Technology in Diagnostic Radiology:
Advances in Breast Imaging
Organising Committee:
Chairman: H. Bosmans; Leuven/BE
Members:
S. Christofides; Nicosia/CY
A. Del Guerra; Pisa/IT
K. Faulkner; Wallsend/UK
A. Torresin; Milan/IT
EF 1Advances in technology
for breast imaging
Moderators: S. Christofides; Nicosia/CY
• Welcome address
S. Christofides; Nicosia/CY
Y. Menu; Paris/FR
• Breast tomosynthesis
P.R. Bakic; Philadelphia, PA/US
• Breast CT
W.A. Kalender: Erlangen/DE • X-ray colour in breast imaging C. Ullberg; Danderyd/SE
EF 2Screening and diagnostic
breast imaging
Moderators: K. Faulkner; Wallsend/UK
J.N. Vassileva; Sofia/BG
• QA, image quality and dose in screening
with digital mammography
H. Bosmans; Leuven/BE
• MRI diagnostic breast imaging
K. Gilhuijs; Utrecht/NL
• Is there a future for radioisotope breast imaging?
S. Ziegler; Munich/DE
69
E3 – European
Excellence in Education
Foundation Course: Paediatric Radiology
E³ 320b Genitourinary problems:
common daily practice
E³ 620b Common musculoskeletal
disorders: how to avoid the traps!
Moderator: V. Donoghue; Dublin/IE
Moderator: A.C. Offiah; Sheffield/UK
A. Imaging strategy in urinary infections
A. Imaging a child with a limp
A. Sprigg; Sheffield/UK
B. Urinary tract dilatation: what should be
done, to whom and when?
F.E. Avni; Brussels/BE
B. Non-accidental injury: a radiologist’s nightmare
P.K. Kleinman; Boston, MA/US
C. Renal and pararenal masses: basic rules
P. Tomà; Rome/IT
C. Bone and joint infection and inflammation:
pearls and pitfalls
G.-H. Sebag; Paris/FR
E³ 420 Common digestive
problems in children:
the radiologist as a key player
E³ 720 Paediatric neuroimaging:
let’s make it simple!
Moderator: A. Paterson; Belfast/UK
Moderator: J.F. Schneider; Basle/CH
A. Abdominal and pelvic pain: a practical approach
S.G.F. Robben; Maastricht/NL
A. Neurosonography in the neonate: rules of thumb
G. Enriquez; Barcelona/ES
B. Jaundice in children: common causes and imaging strategy
D. Pariente; Le Kremlin-Bicêtre/FR
B. Common congenital cerebral abnormalities
A. Rossi; Genoa/IT
C. Neonatal bowel obstruction: the role of the radiologist
S. Ryan; Dublin/IE
C. CNS infection and inflammation: signs you should not miss
E³ 520 Thoracic diseases:
common, important and
potentially devastating
70
E³ 820 What should we know about
antenatal imaging?
Moderator: C. Adamsbaum; Paris/FR
A. Foetal imaging: current practice and
evidence base
C. Garel; Paris/FR
B. Ventricular enlargement and beyond
E.H. Whitby; Sheffield/UK
C. Common chest and abdominal problems
A. Darnell; Barcelona/ES
Moderator: C.E. de Lange; Oslo/NO
A. Investigating a child with a ‘cough’: a pragmatic approach
C. Owens; London/UK
B. Unresolving pneumonia: when and how
to image, and clinical consequences
K. Foster; Birmingham/UK
C. Common cardiac disorders in children:
the basic role of imaging
C.J. Kellenberger; Zurich/CH
Saturday, March 5, 12:15–13:15,
EPOS
Self assessment test
Moderator: V. Donoghue; Dublin/IE
I nteractive computer evaluation of course
learning
E3 – European
Interactive Teaching Sessions
Thursday, March 3, 14:00–15:30, Room B
E³ 120 Commonly missed diagnosis in
musculoskeletal conditions
F. Kainberger; Vienna/AT
K. Bohndorf; Augsburg/DE
Thursday, March 3, 16:00–17:30, Room B
E³ 220a Common radiological problems:
incidental abdominal masses
A. The incidental adrenal mass
R.H. Reznek; London/UK
B. Renal mass
M. Prokop; Nijmegen/NL
Thursday, March 3, 16:00–17:30, Room C
E³ 220b Lung cancer:
what the radiologist must report
A. Staging
A.R. Larici; Rome/IT
B. Follow-up
N. Howarth; Chêne-Bougeries/CH
E³ 320a Thoracic infections:
A. Pulmonary infections
T. Franquet; Barcelona/ES
B. Non-pulmonary chest infections
E³ 620a Cancer of the uterus and cervix:
B. Hamm; Berlin/DE
E³ 1020 Infections of the central
nervous system:
A. ‘Dangerous’ viral and prion infections
G. Wilms; Leuven/BE
B. Bacterial and parasitic infections
E.T. Tali; Ankara/TR
Sunday, March 6, 08:30–10:00, Room B
E³ 1120 Common radiological problems:
palpable lower neck mass –
thyroid or not?
A. Thyroid nodule
H. van Overhagen; The Hague/NL
B. Outside the thyroid
N.J.M. Freling; Amsterdam/NL
E³ 1220 Breast cancer:
A. Tardivon; Paris/FR
Sunday, March 6, 14:00–15:30, Room B
cardiovascular
A. Looking at the heart in chest x-rays
J. Andreu; Barcelona/ES
B. Looking at the heart in chest CT
F. Laurent; Pessac/FR
Monday, March 7, 08:30–10:00, Room B
E³ 1520 Prostate cancer:
A.R. Padhani; Northwood/UK
H.-P. Schlemmer; Heidelberg/DE
71
E3 – European
cognitive decline and dementia
B. Gómez-Ansón; Barcelona/ES
F. Barkhof; Amsterdam/NL
E³ 1720aCommon radiological problems:
incidental chest lesions
A. Solitary pulmonary nodule
E. Castañer; Sabadell/ES
B. Mediastinal mass
J. Vilar; Valencia/ES
E³ 1720bColorectal cancer:
C. Hoeffel; Reims/FR
E³ 1820Female pelvic infections:
72
E3 – European
Titel
73
Accompanying
Sessions
1st ESR/EANM Joint Pre-Congress
Workshop on PET/CT
Wednesday, March 2, 09:00–17:30,
Room C
Organisers: Co-Organiser: É. Breatnach (ESR); Dublin/IE
W. Langsteger (EANM); Linz/AT
M. Beheshti (EANM); Linz/AT
Welcome on behalf of the ESR
09:00–09:15
É. Breatnach; Dublin/IE
Welcome on behalf of the EANM
09:00–09:15
P. Bourguet; Rennes/FR
Instrumentation and technique
09:15–09:45
• Radiology perspective
T. Johnson; Munich/DE
• Nuclear medicine perspective
T. Beyer; Zurich/CH
Radiation exposure
09:45–10:15
H.-C. Becker; Munich/DE
S. Mueller; Essen/DE
Head and neck including
Cancer of Unknown Primary (CUP)
11:00–11:45
R. Hustinx; Liege/BE
Lung cancer
11:45–12:30
F. Gleeson; Oxford/UK
H. Steinert; Zurich/CH
12:30–13:30
GI tumours
13:30–14:15
A. Ba-Ssalamah; Vienna/AT
T. Hany; Zurich/CH
Urogenital tumours
14:15–15:00
C. Nicolau; Barcelona/ES
B. Krause; Munich/DE
15:00–15:30
FDG PET
10:15–10:30
• Physiology, normal distribution and pitfalls
A. Hertel; Fulda/DE
10:30–11:00
Break 1
74
Lunch
Break 2
Accompanying
Sessions
Lymphoma
15:30–16:15
M. O’Connell; Dublin/IE
A. Buck; Munich/DE
Future aspects
16:15–16:45
• Overview of future developments in CT
T. Johnson; Munich/DE
• Tracers beyond FDG in daily routine
M. Beheshti; Linz/AT
Concluding remarks from
the ESR and the EANM
16:45–17:00
Chairs: É. Breatnach; Dublin/IE
W. Langsteger; Linz/AT
Test and quiz with evaluation
17:00–17:30
Chairs: É. Breatnach; Dublin/IE
W. Langsteger; Linz/AT
Registration for the workshop at
www.myESR.org/Pre-congress_Workshop_on_PET-CT
(fee: €100)
75
Accompanying
Sessions
ESOR Session
Coordinators: H.-C. Becker; Munich/DE
Experiencing variety in education
After the great success in the last three years, ECR 2011
will, for the fourth time, feature a ‘Workstation Face-Off ’
session.
Continuous rapid technical advances in CT require state-ofthe-art post processing tools and workstations. Increasingly,
these solutions are based on a thin client-server architecture
which significantly speeds up loading times and workflow.
In the 21st century, radiologists have to be able to interpret
3D datasets and to handle large data volumes. For numerous
applications, dedicated post processing applications are
available. All major vendors offer an ample variety of
hardware and software, and it is often difficult to recognize
the individual strengths and weaknesses of different systems.
Our 4th annual Post Processing Face-Off Session will allow
you to get an impression of the 3D capabilities and large
data volume handling provided by the latest workstation
technology.
Several workstations from different vendors will be set up
on stage next to each other, and a selection of two cases
provided by the ESR will be demonstrated by expert users.
This year, the cases will focus on interpretation of CT
angiographic datasets and complex oncological follow-up
using RECIST 1.1 criteria and a volumetric approach.
The aim of this session is to simulate a realistic ‘reading
room’ atmosphere and to give an impression of how different
workstations perform in a clinical scenario. We would like
to cordially invite you to attend this exciting ‘tournament’
of post-processing!
Moderators:
N. Gourtsoyiannis; Iraklion/GR
During this session, the European School of Radiology
(ESOR), will give an insight into the variety of its educational
programmes and opportunities foreducation in radiology.
• Introduction M.F. Reiser; Munich/DE
• ESOR in action N. Gourtsoyiannis; Iraklion/GR
• Teach the teachers
H. Cameron; Edinburgh/UK
• Widening the vision of teaching in radiology S. Golding; Oxford/UK
• Tutoring in radiology C. Loewe; Vienna/AT
Awards
On the occasion of the session, scholars and fellows will
be awarded certificates for successfully completing the
2010 Visiting Scholarship Programmes and Exchange
Programmes for Fellowships.
Radiology Trainees Forum
RTF Highlighted Lectures
Moderators:
D. Bulja; Sarajevo/BA
P.R. Kornaat; Leiden/NL
• Musculoskeletal trauma in children
I. Boric; Zagreb/HR
• Basic principles in the interpretation of signal
intensities on T1- and T2-weighted images
G. Wilms; Leuven/BE
• Plain film criteria: quality of the x-rays
76
Accompanying
Sessions
EIBIR presents: IMAGINE Workshop
Friday, March 4 to
Sunday, March 6, Room U
Standards and Audit
How to write better reports
Saturday, March 5, 10:30–12:00, Room Z
EIBIR presents this year’s IMAGINE Workshop – a new
concept for ECR visitors. The sessions will feature research
institutes, university groups and research departments of
industrial companies who want to present novel and exciting
technological developments in the field of diagnostic and
interventional radiology.
Focus areas of the IMAGINE Workshop are the development of quantitative imaging biomarkers, computeraided detection and diagnosis, integrated and interactive
visualisation, therapy planning, image-guided interventions
and robotics, and computer-assisted training. The workshop
will feature novel technological developments in diagnosis,
therapy planning and therapy guidance, among others.
Moderator: E.J. Adam; London/UK
Learning objectives:
Moderator: D. Vanel; Bologna/IT
1. T
o learn about the latest developments in quantitative
image analysis, computer-aided diagnosis, and
visualisation in the fields of cardiovascular imaging,
neuro imaging, and oncology.
2. To learn about sophisticated modelling in pre-operative
planning and intra-operative guidance.
• How to write a good radiological report L.P. Lawler; Dublin/IE
• Structured reporting: European perspective R. Silverio; Grosseto/IT
• Structured reporting: improving the quality of radiology reports C.E. Kahn; Milwaukee, WI/US
organised in cooperation with European Hospital
Oral presentations
There will be special sessions in the workshop area, giving
applicants the opportunity to present their work. These
sessions are also open to the public.
Friday, March 4
08:30–10:00
10:30–12:00
Saturday, March 5
14:00–15:30
Workshop (guided tour)
Saturday, March 5
08:30–10:00
10:30–12:00
Sunday, March 6
14:00–15:30
Walk-In Session
Saturday, March 5, 12:00-14:00, Room U
Places will be allocated on a first-come, first-served basis.
Submission Categories
• Cardiovascular image analysis
• Neuro image analysis
• Image analysis in oncology
• Image guided intervention
More information and abstract submission
(until December 31) at myESR.org/IMAGINE2011
77
European Diploma
in Radiology (EDiR)
Prove your excellence! Take the ESR Diploma.
The ESR is proud to announce the launch of the European Diploma
in Radiology (EDiR); a brand new qualification that will provide
General Radiologists with an objective, ESR-endorsed test of their ability.
All parts of the examination will be held in English but non-native
language skills will be taken into consideration by the oral examiners.
The first examination will take place at ECR 2011, on
Monday, March 7, in Vienna.
Apply now at www.myESR.org/diploma!
Accompanying
Sessions
ENCITE Session
EuroAIM Session
Visualisation of cell therapy meets clinical application
Evidence-Based Radiology:
Why is evidence-based radiology crucial?
Moderator: G. Krestin; Rotterdam/NL
The European Network of Cell Imaging and Tracking Expertise
(ENCITE) is pleased to present cutting-edge developments of
novel cell therapies pointing to clinical applications. Within
the European community of cell imaging, this advance is of
specific interest as, according to the recent developments, novel
imaging tools are absolutely vital for the understanding of
therapeutic effects to patients. Three examples of visualisation
show promising results.
• ENCITE – A translational approach
for novel cell therapy applications S. Aime; Torino/IT
• Visualising transplanted neural stem
cells and tissue regeneration by MRI
M. Modo; London/UK
• Imaging dendritic cell vaccinations in melanoma patients M. Srinivas; Nijmegen/NL
• Monitoring of SPIO labelled pancreatic
islets in human liver by MRI M. Hajek; Prague/CZ
• Discussion and exchange
Details: www.encite.org
Moderators:
G. Krestin; Rotterdam/NL
The experts from the European Network for Assessment of
Imaging in Medicine (EuroAIM) will reply to this question.
A special highlight will be the presentation of results of
preliminary analysis focusing on the radiologist’s role in the
production of secondary evidence, which is the best way to
make impact on the whole medical world.
• Applying EBM to radiology – The EuroAIM project F. Sardanelli; Milan/IT
• Secondary evidence for diagnostic imaging L.M. Sconfienza; Milan/IT
• Secondary evidence for interventional radiology D. Vorwerk; Ingolstadt/DE
• The ACRIN experience B.J. Hillmann; Charlottesville, VA/US
Details: www.eibir.org
Moderator: M.M. Thurnher; Vienna/AT
79
Bracco. The Contrast Imaging Specialists.
Solutions for Your Practice
and Your Patients
ia at ECR:
sympos
o
c
c
a
r
B
e
th
s
is
Don’t m
e!
to com
e
r
o
m
…
d
e
n
u
t
Stay
Portfolio
Science
Services
www.braccoimaging.com
Update Your Skills
Practical Courses
Image-Guided Breast Biopsy:
How to do it
Coordinator: M.H. Fuchsjäger; Vienna/AT
Speakers:
I. Schreer; Kiel/DE
Instructors: C.S. Balleyguier; Villejuif/FR
B. Boyer; Paris/FR
C. Dromain; Villejuif/FR
F. Gras, Barcelona/ES
R. Gruber; Vienna/AT
G. Heinz-Peer; Vienna/AT
L. Levy; Paris/FR
M. Locatelli; Gorizia/IT
A. Malich; Nordhausen/DE
I. Miranda; Barcelona/ES
L. Rotenberg; Neuilly-sur-Seine/FR
B. Szabo; Szeged/HU
C.F. Weismann; Salzburg/AT
Percutaneous image-guided needle core biopsy is faster, less
invasive and less expensive than surgical biopsy and has
thus become the alternative for histopathology assessment
of breast lesions. The choice of the respective image
guidance method depends on lesion type (mass lesion,
microcalcifications) as well as the visualisation through
the various diagnostic imaging modalities. This practical
course reviews indications, advantages, limitations and
controversial issues in percutaneous image-guided biopsy
of breast lesions under stereotactic, ultrasound and MR
imaging guidance.
Participants will work on phantoms not only to learn the
device-related technical aspects of the performance but
also how to choose the adequate guidance method, how
to prepare the patient and percutaneous biopsy device,
and how to adequately approach the lesion. Oncological
as well as quality assurance aspects will be emphasised.
The practical training courses are organised to allow time
for each participant to perform interventions under expert
supervision.
1. To comprehend the indications and limitations
of percutaneous image-guided breast biopsy.
2. To understand how to ensure quality standards of
breast biopsy under stereotactic, ultrasound and
MR imaging guidance.
3.
4.
5.
To learn how to chose the adequate imaging
guidance modality and prepare the patient accordingly.
To be able to select the appropriate percutaneous
biopsy device (automated large core or directional
vacuum-assisted biopsy probe).
To be able to perform breast biopsies under
stereotactic, ultrasound and MR imaging guidance
in accordance to international standards.
Introductory lectures:
• Indications, limitations and controversies
for ultrasound-guided breast biopsy
I. Schreer; Kiel/DE
for stereotactic-guided breast biopsy
for MR imaging-guided breast biopsy
Registration:
The number of participants for each course is restricted.
Participants need to register in advance for the practical
training courses (www.myESR.org) as of October 1, 2010,
and must pay a fee of €50. Important details, including the
schedule for the subscribed courses, are indicated on the
confirmation/invoice.
Attendance at the lecture session on Thursday afternoon
is mandatory to participate in the pre-registered practical
training courses.
Schedule:
Thursday, March 3
SK 123 14:00–15:30 Introductory Lectures (Room P)
Friday, March 4
SK 323 08:30–10:00
SK 423 10:30–12:00
SK 523 14:00–15:30
SK 623 16:00–17:30
US guidance
Stereotactic guidance
MR imaging guidance
Saturday, March 5
SK 723 08:30–10:00
SK 823 10:30–12:00
SK 923 14:00–15:30
SK 1023 16:00–17:30
US guidance
MR imaging guidance
US guidance
Sunday, March 6
SK 1123 08:30–10:00
SK 1223 10:30–12:00
SK 1323 14:00–15:30
SK 1423 16:00–17:30
US guidance
MR imaging guidance
MR imaging guidance
81
EU.DI.05.2009.0093 October 2010
Gadovist® 1.0 mmol/mL solution for injection. Composition: 1 mL solution for injection contains 604.72 mg gadobutrol (equiv. 1.0 mmol) as active ingredient. Excipients: calcobutrol sodium, tromethamol, hydrochloric acid, water for injections. Indications: This medicinal product is for diagnostic use only. Gadovist® 1.0 is indicated in adults, adolescents, and children aged 7 years and older for:
Contrast enhancement in cranial and spinal magnetic resonance imaging (MRI), contrast enhanced MRI of liver or kidneys in patients with high suspicion or evidence of having focal lesions to classify these lesions as benign or malignant, contrast enhancement in magnetic resonance angiography (CE-MRA). Contraindications: Hypersensitivity to the active substance or any of the excipients.
Special warnings and precautions for use: Gadovist® 1.0 should not be used in patients with uncorrected hypokalemia. In patients with severe cardiovascular disease Gadovist® 1.0 should only be administered after careful risk benefit assessment because only limited data are available so far. Gadovist® 1.0 should be used with special care in patients with known congenital long QT syndrome or
a family history of congenital long QT syndrome; with known previous arrhythmias after taking medicinal products that prolong cardiac repolarisation; who are currently taking a medicinal product that is known to prolong cardiac repolarisation e.g. a Class III antiarrhythmic (e.g. amiodarone, sotalol). The possibility that Gadovist® 1.0 may cause torsade de pointes arrhythmias in an individual
patient cannot be excluded (see SPC). Since contrast medium elimination is delayed in patients with severely impaired renal function, the benefits must be weighed very carefully against the risks in such cases. In particularly severe cases, it is advisable to remove Gadovist® 1.0 from the body by extracorporeal haemodialysis: For removal of the agent from the body, at least 3 dialysis sessions within
5 days of the injection should be performed. No impairment of renal functions has been observed during clinical trials performed on a limited number of patients. Data are too limited to exclude the possibility of renal toxicity or aggravation of renal impairment. There have been reports of nephrogenic systemic fibrosis (NSF) associated with use of some gadolinium-containing contrast agents in
patients with severe renal impairment (GFR < 30ml/min/1.73m2). As there is a possibility that NSF may occur with Gadovist® 1.0, it should only be used in these patients after careful consideration. Haemodialysis shortly after Gadovist® 1.0 administration in patients currently receiving haemodialysis may be useful at removing Gadovist® 1.0 from the body, but its potential to prevent NSF is unknown
and should not be used as a preventative measure in other patient groups. Hypersensitivity reactions, as have been reported for other contrast media containing gadolinium, have also been observed after administration of Gadovist® 1.0. In patients with an allergic disposition the decision to use Gadovist® 1.0 must be made after particularly careful evaluation of the risk-benefit ratio. In rare cases
delayed anaphylactoid reactions (after hours to days) have been observed. Like with other gadolinium containing contrast agents special precaution is necessary in patients with a low threshold for seizures. Undesirable effects: Following adverse reactions have been observed in clinical trials. Uncommon (≥ 1/1,000 to < 1/100): Headache, Dizziness, Paresthesia, Dysgeusia, Nausea, Vasodilatation,
Injection site pain, Injection site reaction. Rare (≥ 1/10,000 to < 1/1,000): Parosmia, Dyspnoea, Vomiting, Urticaria, Rash, Hypotension, Anaphylactoid reaction. Following additional adverse reactions have been reported from postmarketing spontaneous reporting: Rare (≥ 1/10,000 to < 1/1,000): Cardiac arrest, Tachycardia, Loss of consciousness, Convulsion, Conjunctivitis, Eyelid oedema, Respiratory
arrest, Bronchospasm, Cyanosis, Oropharyngeal swelling, Cough, Sneezing, Face edema, Hyperhidrosis, Pruritus, Erythema, Circulatory collapse, Flushing, Feeling hot, Malaise, Anaphylactoid shock. Additional safety information: Short-lasting mild to moderate feelings of coldness, warmth or pain at the injection site have been uncommonly observed in association with the venous puncture or
contrast medium injection. On paravascular injection Gadovist® 1.0 may cause tissue pain lasting up to several minutes. Hypersensitivity reactions (e.g. urticaria, rash, vasodilatation) have been uncommonly reported and were mostly of mild to moderate intensity. In rare cases anaphylactoid reactions ranging to shock may occur. Delayed anaphylactoid reactions (after hours to days) have been
observed rarely. Patients with an allergic disposition suffer more frequently than others from hypersensitivity reactions. Date of revision of text: September 2009 Please note: for current prescribing information refer to the package insert and/or contact your local Bayer Schering Pharma organisation. Bayer Schering Pharma AG, 13342 Berlin, Germany. Adverse reactions can be reported to
[email protected]
1 Tombach B, Bohndorf K, Brodtrager W, Claussen CD, Duber C, Galanski M, Grabbe E, Gortenuti G, Kuhn M, Gross-Fengels W, Hammerstingl R, Happel B, Heinz-Peer G, Jung G, Kittner T, Lagalla R, Lengsfeld P, Loose R, Oyen RH, Pavlica P, Pering C, Pozzi-Mucelli R, Persigehl T, Reimer P, Renken NS, Richter GM, Rummeny EJ, Schafer F, Szczerbo-Trojanowska M, Urbanik A, Vogl TJ, Hajek P.
Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trial. Eur Radiol 2008.
2 Frenzel T, Lengsfeld P, Schirmer H, Hutter J, Weinmann HJ. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Invest Radiol 2008; 43(12):817-828.
The Power of Contrast
Q Delivering high diagnostic efficacy 1
isit our
Please v osium
ymp
Lunch S arch 4
Friday, M :30
13
12:30 – 1
Room D
n:
Chairma
(US )
a
L
ng w
Prof. Me
Q Macrocyclic compound –
class with highest stability 2
Update Your Skills
Practical Courses
Musculoskeletal US:
Shoulder and elbow
Coordinator:
E.G. McNally; Oxford/UK
Speakers:
P. Peetrons; Brussels/BE
Instructors:
N. Boutry; Lille/FR
M. Court-Payen; Copenhagen/DK
J. De Rooij; Nijmegen/NL
A.J. Grainger; Leeds/UK
P.J. O’Connor; Leeds/UK
E. Silvestri; Genoa/IT
J. Teh; Oxford/UK
This programme will be in two parts. The first part will
be a live demonstration of US anatomy and examination
techniques for the shoulder and the elbow, coupled with a
review of the common pathological findings in these areas.
The demonstrators will emphasise the important anatomical
features and provide participants with useful tips to get the
most from US examinations in these challenging areas. This
will be followed by small group ‘meet the experts’ practical
training courses where participants can refine their own
examination skills under expert guidance.
1. To understand the applications of
US in these two areas.
2. To see an expert examination performed live.
3. To see examples of common pathology.
4. To have the opportunity for group and
expert appraisal of the delegates’ own techniques.
Introductory lectures:
US of the supraspinatus tendon
• Anatomy and demonstration
• Pathology
US of the elbow
• Anatomy and demonstration
• Pathology
Registration:
The number of participants for each course is restricted.
Participants need to register in advance for the practical
training courses (www.myESR.org) as of October 1, 2010,
and must pay a fee of €50. Important details, including the
schedule for the subscribed courses, are indicated on the
confirmation/invoice.
It is recommended that non-experienced users follow the
introductory lectures before entering the practical training
courses.
Schedule:
Friday, March 4
SK 324 08:30–10:00Introductory Lectures
(Room N/O)
SK 424 10:30–12:30 Practical training course
SK 524 14:00–16:00 Practical training course
Saturday, March 5 SK 824 10:30–12:30
Practical training course
83
Siemens Breast Care Day
Program ECR 2011
Thursday, March 3, 2011
12.30 – 13.30
Siemens Lunch Symposium
Breast Care goes 3D
Room F2, Entrance Level
14.00 - 15.00
Panel Discussion
Breast cancer screening –
The conflicts between medical and business priorities
Room OES250, Entrance Level
14.00 – 15.30
Hands-on-Workshop MR Breast Reading and Reporting
Siemens Experience Lounge in the Austria Vienna Center,
Entrance Level
15.30 – 17.00
Student Workshop
One step from theory to practice – A workshop for students
on digital imaging in breast cancer screening
Room OES250, Entrance Level
16.00 – 17.30
Hands-on-Workshop CT Oncology
Siemens Experience Lounge in the Austria Vienna Center,
Entrance Level
Thursday is Siemens Breast Care Day
Siemens Healthcare invites you to this program which covers the topic of breast care.
The program on March 3, 2011 is part of the European Congress of Radiology in Vienna.
www.siemens.com/ecr-BreastCareDay
Siemens
Breast Care
Day
Satellite
Symposia
SY 1Satellite Symposium organised by
Siemens
Breast care goes 3D
Moderator: D. Uhlenbrock; Dortmund/DE
• Introduction
D. Uhlenbrock; Dortmund/DE
• Automated 3D US breast volume scanning
M. Rutten; ‘s-Hertogenbosch/NL
SuperSonic Imagine
Aixploring the breakthroughs against
cancer and fibrosis
Moderator: C. Cohen Bacrie; Aix-en-Provence/FR
• Digital 3D breast tomosynthesis and its
emerging role in breast cancer diagnosis
J. Barkhausen; Lübeck/DE
• Presentation of clinical benefits of
ShearWave™ elastography worldwide breast
trial: model and final results
C. Cohen Bacrie; Aix-en-Provence/FR
• More than MR-mammography
W.A. Kaiser; Jena/DE
•V
alidation of ShearWave™ elastography worldwide
breast trial model with European cases
F.K.W. Schäfer; Kiel/DE
• Preliminary experience with ShearWave™
elastography in the management of prostate cancer
• ShearWave™ elastography for the
evaluation of liver fibrosis
G. Ferraioli; Pavia/IT
GE Healthcare
Widening clinical capabilities in
MRI: latest advances
• Contributions to patient centric MR
J. Coumans; Waukesha, WI/US
• New 1.5T MR technology in clinical practice
B. Wirth; Lons-le-Saunier/FR
• In search for molecular imaging:
the tri-modality imaging approach
G.K. von Schulthess; Zurich/CH
Bayer Schering Pharma
Advances in contrast enhanced MRI:
efficacy, safety and applications
Moderator: M. Law; Los Angeles, CA/US
• An overview of safety and efficacy for the
gadolinium chelates
V. Runge; Temple, TX/US
• Contrast-enhanced MRI in multiple sclerosis:
applications and strategies
A. Rovira-Cañellas; Barcelona/ES
• VALUE-trial-results from interim analysis
Philips Healthcare
Philips Sonalleve MR-HIFU: innovations
in focused ultrasound therapy solutions
Moderator: T. Andreae; Helsinki/FI
Philips Healthcare
Ingenuity TF PET/MR –
seeing what’s never been seen before
• Ingenuity TF PET/MR: technical overview
P. Maniawski; Cleveland, OH/US
• Ingenuity TF PET/MR: clinical overview
O. Ratib; Geneva/CH
Moderator: T. Havens; Cleveland, OH/US
Bracco
Programme to be announced
SY 8Satellite Symposium jointly
organised by Siemens and
Bayer Schering Pharma
Synergies in CT: for better patient care
Moderator: J.E. Wildberger; Maastricht/NL
• Contrast induced nephropathy:
does it matter for CT applications
U.J. Schoepf; Charleston, SC/US
• CT dose optimisation in paediatrics
M. Siegel; St. Louis, MO/US
• Optimising contrast media application
for modern imaging
A.H. Mahnken; Aachen/DE
• Second generation iterative reconstruction:
initial results
M. Lell; Erlangen/DE
85
- Design: ©
Xenetix® 350, solution for injection (350 mgI/ml) ; Xenetix® 300, solution for injection (300 mgI/
ml) ; Xenetix® 250, solution for injection (250 mgI/ml) – Composition per 100 ml: Xenetix® 350:
76.78 g of iobitridol (corresponding to 35 g of iodine), Xenetix® 300: 65.81 g of iobitridol
(corresponding to 30 g of iodine), Xenetix® 250: 54.84 g of iobitridol (corresponding to 25 g of iodine)
– Indications and approvals may vary in different countries. Please refer to the local Summary of Product
Characteristics (SPC) before prescribing. CLINICAL PARTICULARS: Therapeutic indications: this product
is for diagnostic use only. Contrast agent for use in: Xenetix® 350: intravenous urography, computed
tomography, intravenous digital substraction angiography, arteriography, angiocardiography –
Xenetix® 300: intravenous urography, computed tomography, intravenous digital substraction angiography, arteriography, angiocardiography, endoscopic retrograde cholangiopancreatography, arthrography, hysterosalpingography – Xenetix® 250: phlebography, computed tomography, intra-arterial
digital substraction angiography, arteriography, endoscopic retrograde cholangiopancreatography –
Posology and method of administration – Contraindication: hypersensitivity to iobitridol or any of
the excipients, history of major immediate or delayed cutaneous reaction (see undesirable effects)
to Xenetix®, manifest thyrotoxicosis, hysterosalpingography during pregnancy. General particulars
corresponding to all iodinated contrast agents: in the absence of any specific studies, myelography
is not an indication for Xenetix®. All iodinated contrast media can cause minor or major reactions that
can be life-threatening. These can occur immediately (within 60 minutes) or be delayed (within 7 days)
and are often unpredictable. Because of the risk of major reactions, emergency resuscitation equipment
should be available for immediate use – Precautions for use – Interaction with other medicinal
products and other forms of interaction – Association requiring precaution of use – Pregnancy and
lactation – Undesirable effects – Pharmacological properties – Pharmaceutical data: For detailed
information contact Guerbet – BP 57400 F-95943 Roissy CdG cedex – Tel: +33.(0)1.45.91.50.00 www.guerbet.com
Creation:
Dotarem® 0.5 mmol/mL, solution for injection in vials and pre-filled syringes – Qualitative and
quantitative composition per 100 mL: Gadoteric acid* (27.932 g) corresponding to DOTA (20.246 g)
– Gadolinium oxide (9.062 g) (*: Gadoteric acid: gadolinium complex of 1,4,7,10 tetraazacyclododedane-N,N’,N’’,N’’’ tetraacetic acid). CLINICAL PARTICULARS: Therapeutic indications: Magnetic
Resonance Imaging for cerebral and spinal disease, diseases of the vertebral column, and the other
whole-body pathologies (including angiography). Indications and approvals may vary in different countries. Please refer to the local SPC before prescribing. Posology and method of administration: The
recommended dose is 0.1 mmol/kg, i.e. 0.2 mL/kg in adults, children and infants. In angiography,
depending on the results of the examination being performed, a second injection may be administered
during the same session if necessary. In some exceptional cases, as the confirmation of isolated metastasis
or the detection of leptomeningaeal tumors, a second injection of 0.2 mmol/kg can be administered.
Contraindications: History of hypersensitivity to gadolinium salts. Contraindications related to MRI:
subjects with a pacemaker, subjects with a vascular clip. Special warnings and precautions for use:
Administer only by strict intravenous injection. Dotarem® must not be administred by subarachnoid
(or epidural) injection. Caution is recommended for anaphylactic-like reactions, renal insuffiency and
CNS disorders. There have been reports of Nephrogenic Systemic Fibrosis (NSF) associated with use
of some gadolinium-containing contrast agents in patients with severe renal impairment (GFR<30 ml/
min/1.73 m²). As there is a possibility that NSF may occur with Dotarem®, it should only be used in
these patients after careful consideration. Interactions with other medicinal products and other forms of
interaction – Pregnancy and lactation – Undesirable effects – Pharmacological properties – Pharmaceutical data: For detailed information, contact GUERBET - BP 57400 – F 95943 Roissy CdG Cedex –
Tel. : +33.(0)1.45.91.50.00 - www.guerbet.com
escapades - P 10069 - October 2010
Guerbet offers unique contrast media
for medical imaging
Satellite
Symposia
Y 9Satellite Symposium organised by
S
GE Healthcare
Hitachi
X-ray advanced applications: clinical
progress and benefits in routine practice
Hitachi real-time tissue elastography
(HI-RTE): from the experts
Moderator: L. Katz; Buc/FR
Moderator: D. Musset; Clamart/FR
• Imaging metal implants: benefits of digital
radiography advanced applications
A. Blum; Nancy/FR
• Welcome and introduction
D. Musset; Clamart/FR
• Digital breast tomosynthesis:
clinical performance and vision
G. Gennaro; Padua/IT
• State of the art Hitachi real-time tissue
elastography: characterisation of focal breast
lesions
A. Thomas; Berlin/DE
• Routine use of digital tomosynthesis for lung
nodule detection: clinical, workflow and
economic impacts
S. Kheddache; Gothenburg/SE
• New aspects in tendon imaging
• Hitachi real-time tissue elastography
in radiology
P.S. Sidhu; London/UK
• Non-invasive evaluation of liver fibrosis
using Hitachi real-time tissue elastography
K. Fujimoto; Tanabe/JP
• Contrast-enhanced spectral mammography:
clinical benefits in diagnostic workflow
C. Dromain; Villejuif/FR
Guerbet
Patient management in oncology:
screening, diagnosis and staging
of colorectal cancer
Moderator: D.-M. Koh; Sutton/UK
• How to improve the patient management in
oncology with complementary techniques?
• Patient acceptance improvement with
minimal bowel preparation in screening
CT colonography
J. Stoker; Amsterdam/NL
• Water-coloCT: an alternative imaging
technique for colon cancer diagnosis
P.-J. Valette; Lyon/FR
• Dynamic MR imaging in liver staging
after colon cancer
T.J. Vogl; Frankfurt a. Main/DE
• Whole-body staging with contrast-enhanced
PET-CT
G. Antoch; Essen/DE
Philips Healthcare
Ingenia 1.5T and 3.0T: the first-ever
digital broadband MRI systems
Moderator: J. van den Bremer; Eindhoven/NL
• Introduction
C. Smits; Latham, NY/US
• Clinical experiences with Ingenia 1.5T
T. Leiner; Utrecht/NL
• Clinical experiences with Ingenia 3.0T
V. Vandecaveye; Leuven/BE
Philips Healthcare
Advances in radiology ultrasound using
iU22 xMATRIX technology
Moderator: E. Danse; Brussels/BE
• Liver and renal 3D conventional and
contrast-enhanced US using the iU22
xMatrix system: technical innovation or
clinical revolution
• xMatrix ultrasound: the power of CT/MR in
your hand
S.T. Elliott; Newcastle upon Tyne/UK
• Questions and conclusion
87
Satellite
Symposia
SY 14Satellite Symposium jointly
organised by Bracco and Toshiba
Contrast enhanced ultrasound (CEUS):
the effective imaging solution
Moderator: M. Claudon; Vandoeuvre-les-Nancy/FR
•N
ew clinical data to support DCE-US as the
imaging modality for the monitoring of antiangiogenesis therapies efficacy
N. Lassau; Villejuif/FR
GE Healthcare
Promise of advanced oncology imaging
Moderator: R.C. Sigal; Velizy/FR
• Latest guidance technologies for
interventional oncology
• Advanced 3T MRI of gastrointestinal oncology
M. Zins; Paris/FR
•E
valuation of the clinical impact of CEUS in
the treatment of abdominal aneurysm
V. Cantisani; Rome/IT
• Th
e role of CEUS in the assessment of renal graft:
immediate and long term transplant follow-up
T. Fischer; Berlin/DE
• MR guided focused ultrasound (MRgFUS)
for treating oncology patients
C. Catalano; Rome/IT, A. Napoli; Rome/IT
• The role of fusion imaging in complex
biopsy and ablative procedures
Hologic
The use of breast tomosynthesis
in clinical practice
Moderator: A. Smith; Bedford, MA/US
Siemens
Shaping the future of molecular and
magnetic resonance imaging
Moderator: M. Schwaiger; Munich/DE
•R
educing CT dose in myocardial
perfusion SPECT/CT
E. O’Shaughnessy; Poole/UK
•W
hole-body MR-PET: first experiences
M. Schwaiger; Munich/DE
•C
linical relevance and potential of 3 Tesla
for musculoskeletal imaging: first experiences
using MAGNETOM Skyra
T.C. Mamisch; Berne/CH
Sectra
How new technology can improve cancer
detection and lower radiation dose in
mammography
Moderator: M. Danielsson; Solna/SE
H. Ringertz; Linköping/SE
• Risk of radiation-induced breast cancer in
mammographic screening
M.J. Yaffe; Toronto, ON/CA
• 10 years of breast screening in Ireland: clinical
review and impact of digital imaging
F. Flanagan; Dublin/IE
• Breast tomosynthesis: an overview and
results from the first prospective clinical
study comparing tomosynthesis to 2 view
and 1 view 2D mammography
M.G. Wallis; Cambridge/UK
• First clinical results of single shot spectral
imaging in mammography
M. Danielsson; Solna/SE
Satellite
Symposia
GE Healthcare
Redefining the rules of CT imaging: new
frontiers for patient care and image quality
Moderator: A. Laghi; Latina/IT
• New insights from contrast media research
J.A. Jakobsen; Oslo/NO
• Gemstone spectral imaging (GSI):
a significant advance in the diagnostic
performance of CT for emergency imaging?
J. de Mey; Brussels/BE
•U
ltra low dose abdominal CT with iterative
reconstruction technologies: how low can you go?
M.M. Maher; Cork/IE
Philips Healthcare
Innovative approaches with CT
Moderator: L. De Vries; Amsterdam/NL
• Liver anatomical segmentation: an innovative
approach and software application
P.-J. Valette; Lyon/FR
• First experiences with iDOSE - dose
reduction and better image quality
M. Dobritz; Munich/DE
Bracco
Programme to be announced
Siemens
Pioneering innovations in ultrasound
• Acoustic radiation force imaging (ARFI):
repeatability of measurements and
assessment in relation to immediate
targeted liver biopsy
P.S. Sidhu; London/UK
• Strain imaging and automated ultrasound
in the breast
C.S. Balleyguier; Villejuif/FR
• Automated image fusion: a new processing
approach in clinical use
D.-A. Clevert; Munich/DE
89
s I m p ly b e T T e r .
The brilliant combination of safety,
efficiency and flexibility.
ulrich medical® CT ConTrasT agenT InjeCTor
NEW
For more than 25 years contrast
agent injectors of ulrich medical
help radiologists in precise
diagnostic imaging.
The technical question still driving
us after all these years: How can
we even better combine the
highest levels of safety, efficiency
and flexibility?
Our answer is the CT motion.
Not available in U.S., pending 510k clearance.
ECR 2011 Expo C Booth 326
ulrich GmbH & Co. KG l Buchbrunnenweg 12 l 89081 Ulm l Germany
Phone: +49 (0)731 9654-0 l Fax: +49 (0)731 9654-2805
[email protected] l www.ulrichmedical.com
90
Industry
Hands-On Workshops
Thursday, March 3 to
Sunday, March 6, Siemens
Experience Lounge, OE – entrance level
Industry Hands-On Workshop
organised by Siemens Healthcare
Clinical experts will demonstrate to you how to better
use and further benefit from our solutions for advanced
multimodality reading. A special focus will be placed
on the new imaging software syngo.via. Benefit from
experts’ experience and receive an update on state-of-theart techniques in CT, MR and Molecular Imaging. As a
registered attendee for ECR 2011 these workshops are free
of charge. Programme to be announced.
Friday, March 4 to Monday, March 7,
Osirix Hands-On Workshop Room,
01 – 1st level
organised by aycan
About OsiriX PRO Medical images present a steadily growing challenge. In
these Hands-On Workshops, we introduce you to the
latest state of medical image postprocessing. Attendees can
follow the session’s contents on provided Apple Macintosh
workstations.
• Agenda Basic Course:
OsiriX PRO Basics, Import/Export, 2D-Viewer,
Reviewing, Thickslab/MPR/MIP, Teleradiology with iPad.
• Agenda Advanced Course I:
Volumetric Analysis, 3D Volume Rendering,
Segmentation, Bone Removal.
• Agenda Advanced Course II:
Fusion, 3 point based registration, 4D analysis.
• Agenda Advanced Course III:
Sizing of AAA Stentgrafts.
Saturday, March 5 and
Sunday, March 6, 09:00–18:00,
Carestream Health Industry Hands-On
Workshop Room, 01 – 1st level
organised by Carestream Health
Digital Mammography Self-assessment Workshop
Goals and Objectives:
Following completion of this programme, the participants
should be more familiar with reading and manipulating
digital mammography screening cases and will have
assessed their reading skills to detect cancers in their early
stage and to maintain a good balance between recall rate
and detection rate.
This workshop gives participants the opportunity for
hands-on experience. Participants may register for up
to seven one-hour sessions. Each session starts with an
introduction that includes the learning objectives of the
workshop, the method of reading and self-assessment and
instruction on how to use the system.
Participants will have 45 minutes to read the cases,
and then assess their own number of false positives
and false negatives, and discuss the cases with medical
experts. Participants will be able to choose between a
total of seven different modules, each one containing
30 selected mammography screening cases with a mix
of biopsy-proven positives and negatives. Each module
is independent of the others; they do not need to be
completed sequentially.
Instructors:
R. Holland; Nijmegen/NL
U. Bick; Berlin/DE
Philips Healthcare
Industry Hands-On Workshop Room,
01 – 1st level
organised by Philips Healthcare
Programme to be announced.
No pre-registration required, registration at room entrance
/ first come first served basis.
Registration for the Industry Hands-On Workshops
is possible via the MyUserArea on www.myESR.org
91
Dignitaries
ECR 2011
Borut Marincek
Kilchberg/CH
Gold Medallist
Borut Marincek is Professor emeritus
of Radiology at the University of Zurich,
Switzerland, where he has served since 1997.
He is the author or co-author of more than 290
peer-reviewed articles, more than 50 books
and book chapters and has given more than
220 lectures, orations and invited lectures in
Europe and overseas. Although well known
for his work in gastrointestinal and abdominal
radiology, Professor Marincek has maintained a
broad focus throughout his career, and includes
genitourinary, oncologic, cardiovascular and
emergency radiology among his scientific
interests. He sits on the editorial boards of
several journals, including the Advisory
Editorial Board of European Radiology, has
received honours from many national and
international radiological societies and is a
recent past president of the European Society
of Gastrointestinal and Abdominal Radiology
and the European Congress of Radiology (both
2009). At ECR 2011 he will be awarded the
Gold Medal of the ESR.
Martine Rémy-Jardin
Lille/FR
Gold Medallist
Martine Rémy-Jardin is Professor of Radiology
and Head of the Department of CardioThoracic Imaging at the University Centre of
Lille. Her fields of interest include HRCT of
diffuse infiltrative lung diseases, pulmonary
vascular diseases, and cardiac and pulmonary
functional imaging, but the major focus of
her research has been spiral CT imaging. Her
published works comprise 220 peer-reviewed
publications, 75 postgraduate publications,
377 scientific papers, and 39 books and
chapters. She has been a regular reviewer for
several journals, currently including European
Radiology, and is a member of numerous
professional and scientific societies, including
the American Thoracic Society, the Society of
Thoracic Radiology, the European Society of
Thoracic Imaging, the European Respiratory
Society, the French Society of Thoracic
Imaging, and the French Society of Radiology,
for which she served as President of the
Scientific Committee from 1995 to 2006. At
ECR 2011 she will be presented with the Gold
Medal of the ESR.
92
Ralph Weissleder
Charlestown, MA/US
Gold Medallist
Ralph Weissleder is Professor of Radiology and
Professor of Systems Biology at Harvard Medical
School, and Director of the Massachusetts General
Hospital (MGH) Center for Systems Biology. He is
also Attending Clinician (Interventional Radiology)
at MGH as well as a member of the Dana-Farber/
Harvard Cancer Center, the Broad Institute and the
Harvard Stem Cell Institute (HSCI). Dr. Weissleder’s
research interests include the development of
novel molecular imaging techniques, tools for
early disease detection, nanomaterials for sensing,
and systems analysis. He has published over 500
original publications in peer-reviewed journals
and has authored several textbooks. His work has
been honoured with numerous awards including
the J. Taylor International Prize in Medicine, the
Millennium Pharmaceuticals Innovator Award, and
the 2008 RSNA Outstanding Researcher Award. In
2009, he was also elected as a member of the US
National Academies Institute of Medicine. At ECR
2011 he will be awarded the Gold Medal of the ESR.
Denis Le Bihan
Gif-sur-Yvette/FR
Opening Lecturer
Denis Le Bihan is the Founding Director of
NeuroSpin, a new Institute aimed at developing
and using ultra-high-field magnetic resonance
to understand the brain. He has authored or coauthored over 250 articles, book chapters and review
articles in the fields of MRI, imaging, neuroscience
and radiology. His work has achieved international
recognition for his outstanding contributions to the
development of new imaging methods, including
the Gold Medal of the International Society for
Magnetic Resonance in Medicine, the Lounsbery
Award from the National Academy of Sciences
(USA) and French Academy of Sciences, and the
Louis D. Award of the Institut de France. Dr. Le
Bihan is a full member of the French Academy of
Sciences, an Honorary Member of the American
Society of Neuroradiology and a Knight of the
French National Order of Merit. At ECR 2011 he
will give the Opening Lecture ‘Water: radiologists’
best friend?’
Byung Ihn Choi
Seoul/KR
Honorary Membership
Byung Ihn Choi is Professor at the
Department of Radiology of Seoul National
University, College of Medicine in Korea and
is an internationally recognised abdominal
radiologist, particularly in the field of
hepatobiliary imaging. Having worked at a
variety of institutions across the USA and in
Tokyo between 1985 and 1994, Dr. Choi has
greatly contributed to the international profile
of Korean radiology. Throughout his career he
has published more than 600 scientific papers,
while also serving on the editorial boards of
numerous national and international journals.
He is currently president of the Asian Oceanian
Society of Radiology (AOSR), and the Korean
Association for the Study of the Liver (KASL),
and president-elect of the Asian Society
of Abdominal Radiology (ASAR), and his
contributions to international radiology have
led to honorary membership of many regional
and international radiological societies. He
will be awarded Honorary Membership of the
European Society of Radiology at ECR 2011.
Jian-Ping Dai
Beijing/CN
Honorary Membership
Jian-Ping Dai is a professor at the Radiology
Department of the Beijing Neurosurgical
Institute and Beijing Tiantan Hospital,
Capital Medical University, where he is also
chairman of his department. He is a tireless
educator and tutor and is well known as
one of the most influential characters in the
development of radiology in China. Dr. Dai
has focused his research on interventional
therapy for cerebrovascular disease and
functional neuroimaging and has received
several awards from the Chinese government
for his outstanding contribution to his country.
During his presidency of the Chinese Society
of Radiology from 1996 to 2005, radiology
in China accelerated its development and
communication with other radiological
societies such as the European Society of
Radiology, the Radiological Society of North
America, and the Asian Oceanian Society of
Radiology. At ECR 2011 Dr. Dai will receive
Honorary Membership of the European
Society of Radiology..
Hedvig Hricak
New York, NY/US
Honorary Membership
Hedvig Hricak is Chairman of the Department
of Radiology at Memorial Sloan-Kettering
Cancer Center (MSKCC) and Professor of
Radiology at the Weill Medical College of
Cornell University. She was previously a
professor of radiology, radiation oncology,
urology and gynaecology at the University of
California at San Francisco. She has authored
or co-authored 343 peer-reviewed original
research articles, 159 review/editorial articles,
132 book chapters and 18 books, and given
more than 135 named or keynote lectures.
She is a member of the Institute of Medicine,
National Academy of Science. She is a fellow
of the American College of Radiology, the
International Society for Magnetic Resonance
in Medicine, and the Society of Uroradiology
and her many awards include the gold medals
of the International Society for Magnetic
Resonance in Medicine and the Association
of University Radiologists, the Béclère Medal
from the International Society of Radiology, the
Moroccan Merit Medal from the International
Society of Radiology and the Order of the
Croatian Morning Star of Katarina Zrinska,
Presidential Award from Croatia. Dr. Hricak
is the current Immediate Past President of
the Radiological Society of North America.
At ECR 2011 she will be awarded Honorary
Membership of the European Society of
Radiology.
93
Dignitaries
ECR 2011
Richard L. Baron
Chicago, IL/US
Honorary Lecturer
Richard L. Baron is currently chairman of the
Department of Radiology at the University
of Chicago, where he has served since 2002.
He was the founding President and CEO of
the University of Pittsburgh Physicians, an
academic healthcare enterprise of over 1,400
physicians, and served in that role from 1997
to 2002. Dr. Baron has over 135 published
articles and 26 book chapters, predominately in
liver and biliary tract imaging and has been the
recipient of numerous awards for his research,
including the Hounsfield Award from the
Society of Computed Body Tomography and
Magnetic Resonance and The Roscoe E. Miller
Award from the Society of Gastrointestinal
Radiologists. At ECR 2011 he will present the
Wilhelm Conrad Röntgen Honorary Lecture
‘Detecting liver tumours: the search for the
Holy Grail’.
José Cáceres
Barcelona/ES
Honorary Lecturer
José Cáceres is Professor and Chief of
Diagnostic Radiology at H.G.U. Vall d’Hebron
Universidad Autónoma, Barcelona. An
outstanding radiologist with a focus on
thoracic imaging, Professor Cáceres is well
recognised as an exceptional educator in his
field and has received numerous honours for
his contributions to the discipline, including
the Gold Medal of the Spanish Society of
Radiology. He has shared his expertise in chest
radiology by serving as the chest imaging
section editor for European Radiology and
by chairing the chest subcommittee of the
European Congress of Radiology three times.
He is also a past president of the European
Society of Chest Radiology and the Spanish
Society of Thoracic Imaging, receiving
honorary membership of both societies. At
ECR 2011 he will present the Josef Lissner
Honorary Lecture ‘The chest radiograph:
a perfect design’.
94
Majda M. Thurnher
Vienna/AT
Honorary Lecturer
Majda M. Thurnher is Associate Professor of
Radiology at the Medical University of Vienna, a
position she has held since 2001. Her primary focus
is on neuroradiology, especially spinal imaging,
and she has shared her experience throughout
Europe and the USA as a visiting professor. Her
published work includes 49 peer-reviewed articles,
21 book chapters and 86 scientific papers, and she
has contributed as a reviewer and editorial board
member to numerous national and international
journals, including guest editorship of special
issues of European Radiology and Neuroimaging
Clinics of North America. She has delivered more
than 130 invited lectures at international meetings
and has been a regular member of the Programme
Planning Committee for the European Congress of
Radiology (ECR). She is a member of the executive
boards of several scientific societies, including the
European Society of Neuroradiology (ESNR) and
the American Society of Spine Radiology (ASSR).
At ECR 2011 she will give the Pierre et Marie Curie
Honorary Lecture „Beyond morphology and into
physiology: newer spine imaging techniques“.
Marc Ghysels
Brussels/BE
Guest Lecturer
Marc Ghysels is a 50-year-old Belgian radiologist
who has acquired an international reputation among
art collectors, dealers, curators and experts working
in auction rooms for his radiological analysis of art
works. After specialising in interventional radiology
at Erasme Hospital in Brussels, Thomas Jefferson
Hospital in Philadelphia and Hammersmith
Hospital in London, he worked in hospitals for
fifteen years before establishing a private radiology
practice in Brussels, analysing antiquities and art
works from a wide range of cultures. Art specialists
worldwide have called on his radiological skills and
knowledge to detect the methods used to make
art works, what damage they have suffered, how
much restoration has been done, and to expose the
tricks used by forgers to deceive other methods of
scientific analysis. At ECR 2011 he will present the
Guest Lecture ‘Slicing through Antiques & Works
of Art’.
Invited Lectures
ECR 2011
Opening Lecture
Honorary Lectures
Thursday, March 3, 18:55–19:15, Room A
Water: radiologists’ best friend?
Josef Lissner Honorary Lecture
Denis Le Bihan; Gif-sur-Yvette/FR
Guest Lecture
Slicing through Antiques & Works of Art
Marc Ghysels; Brussels/BE
The chest radiograph: a perfect design
José Cáceres; Barcelona/ES
Pierre et Marie Curie
Honorary Lecture
Beyond morphology and into physiology:
newer spine imaging techniques
Majda M. Thurnher; Vienna/AT
Wilhelm Conrad Röntgen
Honorary Lecture
Detecting liver tumours:
the search for the Holy Grail
Richard L. Baron; Chicago, IL/US
95
Concerts
kammerorchesterbasel, conductor Kristjan Järvi
Angelika Kirchschlager, mezzo-soprano
J. Sibelius, R. Wagner, E. Grieg
Artemis Quartett, string quartet
L. van Beethoven
Wiener Symphoniker,
conductor Adam Fischer
Denis Matsuev, piano
Z. Kodály, F. Liszt, J. Brahms
Concentus Musicus Wien,
conductor Nikolaus Harnoncourt
Arnold Schönberg Chor
G.F. Händel
Latvian National Symphony Orchestra,
conductor Karel Mark Chichon
Elina Garanca, mezzo-soprano
G. Verdi, G. Donizetti, N. Rimski-Korsakow, G. Bizet
in Vienna
Tonkünstler-Orchester Niederösterreich,
conductor Michail Jurowski
Lars Vogt, piano
C.M. von Weber, L. van Beethoven,
D. Shostakovich
Rolando Villazón, tenor
Gerold Huber, piano
Songs by R. Schumann
Klangforum Wien, conductor
Emilio Pomárico
Marisol Montalvo, soprano
I. Yun, N. Obuchow, A. Jolivet, K. Szymanowski
ORF Radio Symphonie Orchester Wien,
conductor Peter Eötvös
Natalia Zagorinskaya, soprano
Carolin Widmann, violin
Z. Kodály, P. Eötvös, G. Kurtág, B. Bartók
Tonkünstler-Orchester Niederösterreich,
conductor Andrés Orozco-Estrada
Flamenco
Thomas Quasthoff, baritone
András Schiff, piano
Songs by H. Wolf, G. Mahler
Antigone
By Sophokles
Theatre
Die Pappenheimer oder Das O der Anna O.
By Franzobel
Der Parasit
By Friedrich Schiller
Was ihr wollt
By William Shakespeare
Das weite Land
By Arthur Schnitzler
Die Beteiligten
By Kathrin Röggla
Das blinde Geschehen
By Botho Strauß
Rausch
By August Strindberg
Phaedra
By Jean Racine
in Vienna
lieber schön
By Neil LaBute
Heldenplatz
By Thomas Bernhard
Die heilige Johanna der Schlachthöfe
By Bertolt Brecht
Die Ratten
By Gerhard Hauptmann
Drei Schwestern
By Anton Tschechow
Ein Monat auf dem Lande
By Iwan Turgenjew
Lulu
By Frank Wedekind
ESR
Executive Council
(March 2010 – March 2011)
Maximilian F. Reiser; Munich/DE
President
András Palkó; Szeged/HU
1st Vice-President
Gabriel P. Krestin; Rotterdam/NL
2nd Vice-President
Christian J. Herold; Vienna/AT
Past-President
Yves Menu; Paris/FR
Congress Committee Chairman
Lorenzo Bonomo; Rome/IT
1st Vice-Chairman of the Congress Committee
José I. Bilbao; Pamplona/ES
2nd Vice-Chairman of the Congress Committee
Adrian K. Dixon; Cambridge/UK
Publications Committee Chairman
Luis Martí-Bonmatí; Valencia/ES
Research Committee Chairman
Éamann Breatnach; Dublin/IE
Education Committee Chairman
Luís Donoso; Barcelona/ES
Professional Organisation Committee Chairman
Fred E. Avni; Brussels/BE
Subspecialties Committee Chairman
Guy Frija; Paris/FR
National Societies Committee Chairman
Luigi Solbiati; Busto Arsizio/IT
Communication & International Relations
Committee Chairman
Katrine Åhlström Riklund; Umea/SE
Finance Committee Chairperson
Peter Baierl; Vienna/AT
Executive Director
N. Gourtsoyiannis; Iraklion/GR
ESOR Scientific/Educational Director
100
ECR 2011
Committees
CONGRESS COMMITTEE
Chairperson (Congress President)
Y. Menu; Paris/FR
1st Vice-Chairperson
(1st Congress Vice-President)
L. Bonomo; Rome/IT
2nd Vice-Chairperson
(2nd Congress Vice-President)
Ordinary Members
V.E. Sinitsyn; Moscow/RU
B. Hamm; Berlin/DE
Ex-officio Members:
Chairperson of the
Finance Committee
K. Åhlström Riklund; Umea/SE
ESR President
Chairperson of the
Publications Committee
ESR Executive Director
P. Baierl; Vienna/AT
PROGRAMME PLANNING COMMITTEE
Postgraduate Educational
Programme
Chairman:
Members:
D. Akata; Ankara/TR
M. Maas; Amsterdam/NL
M.G. Mack; Frankfurt a. Main/DE
K. Nikolaou; Munich/DE
R. Salvador; Barcelona/ES
J. Votrubová; Prague/CZ
M. Zanetti; Zurich/CH
Scientific Papers
Chairman:
V.E. Sinitsyn; Moscow/RU
Members:
E. de Kerviler; Paris/FR
C. Loewe; Vienna/AT
A. Trojanowska; Lublin/PL
Scientific Exhibition (EPOS™)
Cases of the Day
Chairman:
R. Hermans; Leuven/BE
Members:
I. Björkman-Burtscher; Lund/SE
I. Lupescu; Bucharest/RO
Categorical Courses
B. Hamm; Berlin/DE
A.M. Davies; Birmingham/UK
E³ – European Excellence in
Education:
Foundation Course
V. Donoghue; Dublin/IE
Physics Programme
D. Vanel; Bologna/IT
M.M. Thurnher; Vienna/AT
Evaluation
G.A. Krombach; Aachen/DE
Publications Committee Chairman
e-Learning
P. Pokieser; Vienna/AT
101
ECR 2011
Committees
SCIENTIFIC SUBCOMMITTEES
The ESR would like to thank ESGAR for
their cooperation on this subcommittee
Cardiac
The ESR would like to thank ESCR for
Chairmen:
H. Fenlon; Dublin/IE
C. Triantopoulou; Athens/GR
Chairman:
A.J.B.S. Madureira; Porto/PT
Members:
C. Ayuso; Barcelona/ES
M.A. Bali; Brussels/BE
A. Ba-Ssalamah; Vienna/AT
R. Bouzas; Vigo/ES
D.J. Breen; Southampton/UK
L. Curvo-Semedo; Coimbra/PT
J.B. Dormagen; Oslo/NO
S. Gourtsoyianni; Iraklion/GR
U. Korman; Istanbul/TR
P. Leander; Malmö/SE
T. Mang; Vienna/AT
M.A. Patak; Zurich/CH
F. Pilleul; Lyon/FR
S. Rafaelsen; Vejle/DK
S. Romano; Naples/IT
S. Stojanovic; Novi Sad/RS
C. Stoupis; Maennedorf/CH
Z. Tarján; Budapest/HU
S.A. Taylor; London/UK
M. Zins; Paris/FR
Breast
The ESR would like to thank EUSOBI for
Chairman:
G. Esen; Istanbul/TR
Members:
H. Dobson; Glasgow/UK
M.H. Fuchsjäger; Vienna/AT
G. Kirova; Sofia/BG
A. Malich; Nordhausen/DE
F. Thibault; Paris/FR
J. Veltman; Nijmegen/NL
102
Members:
H. Alkadhi; Zurich/CH
G. Feuchtner; Innsbruck/AT
M. Gardarsdottir; Reykjavik/IS
S. Katsilouli; Athens/GR
K.-F. Kreitner; Mainz/DE
E. Mershina; Moscow/RU
L. Natale; Rome/IT
A.P. Parkar; Bergen/NO
J.-F. Paul; Le Plessis Robinson/FR
C. Peebles; Southampton/UK
D. Piotrowska-Kownacka; Warsaw/PL
P.K. Vanhoenacker; Aalst/BE
Chest
The ESR would like to thank ESTI for
Chairman:
M.-L. Storto; Chieti/IT
Members:
E. Castañer; Sabadell/ ES
W.F.M. De Wever; Leuven/BE
S.R. Desai; London/UK
B. Feragalli; Chieti/IT
I. Hartmann; Rotterdam/NL
K. Marten; Göttingen/DE
J. Neuwirth; Prague/CZ
A. Oikonomou; Alexandroupolis/GR
H. Prosch; Vienna/AT
M.-P. Revel; Paris/FR
E. Rizzo; Lausanne/CH
K. Vidmar Kocijancic; Ljubljana/SI
The ESR would like to thank EuroPACS
for their cooperation on this subcommittee
Chairman:
E. Pietka; Gliwice/PL
Members:
J. Fernandez-Bayó; Sabadell/ES
T.G. Maris; Iraklion/GR
E. Neri; Pisa/IT
M. Onu; Bucharest/RO
O. Ratib; Geneva/CH
L.N. Sutton; Halifax/UK
Molecular Imaging and
Contrast Media
Chairman:
P. Reimer; Karlsruhe/DE
Members:
S. Chatziioannou; Athens/GR
A. Cuocolo; Naples/IT
B. Elmståhl; Malmö/SE
L.S. Fournier; Paris/FR
A.M. Herneth; Vienna/AT
G.G. Karmazanovsky; Moscow/RU
A.J. van der Molen; Leiden/NL
M. Wozniak; Lublin/PL
Genitourinary
The ESR would like to thank ESUR for
Chairman:
B. Brkljačić; Zagreb/HR
Members:
D. Beyersdorff; Berlin/DE
F. Cornud; Paris/FR
F.M. Danza; Rome/IT
P. Liss; Uppsala/SE
H.J. Michaely; Mannheim/DE
S. Moussa; Edinburgh/UK
D. Negru; Iasi/RO
F. Papadopoulou; Ioannina/GR
A.T. Turgut; Ankara/TR
A. Vargha; Hidegség/HU
Head and Neck
The ESR would like to thank ESHNR for
Chairman:
H.C. Thoeny; Berne/CH
Members:
E. Arana; Valencia/ES
D. Cuzino; Bucharest/RO
N. Gritzmann; Vienna/AT
P.-Y. Marcy; Nice/FR
J. Olliff; Birmingham/UK
L. Preda; Milan/IT
B. Verbist; Leiden/NL
ECR 2011
Committees
The ESR would like to thank CIRSE for
Neuro
The ESR would like to thank ESNR for
Radiographers
The ESR would like to thank ISRRT for
Chairman:
P.E. Andersen; Odense/DK
Chairman:
P.C. Maly Sundgren; Malmö/SE
Members:
A. Basile; Catania/IT
C. Binkert; Winterthur/CH
E. Boullosa; Vigo/ES
M. Glynos; Athens/GR
P. Haage; Wuppertal/DE
M. Januszewicz; Warsaw/PL
J. Kettenbach; Berne/CH
A. Krajina; Hradec Králové/CZ
A.G. Ryan; Waterford City/IE
T. Sabharwal; London/UK
C. Tziakouri-Shiakalli; Nicosia/CY
O.M. van Delden; Amsterdam/NL
Members:
N. Bargalló; Barcelona/ES
V. Dousset; Bordeaux/FR
J. Fiehler; Hamburg/DE
Z. Merhemic; Sarajevo/BA
M. Muto; Naples/IT
L. Østergaard; Århus/DK
I. Saatci; Ankara/TR
M. Sasiadek; Wroclaw/PL
T. Stosic-Opincal; Belgrade/RS
J.W.M. van Goethem; Antwerp/BE
P. Vilela; Almada/PT
T.A. Yousry; London/UK
Chairmen:
B.T. Andersson; Lund/SE
S.J. Golding; Oxford/UK
Musculoskeletal
The ESR would like to thank ESSR for
Chairman:
E. Llopis; Valencia/ES
Members:
G.M. Allen; Oxford/UK
F. Birsasteanu; Timisoara/RO
P.M. Cunningham; Navan/IE
J.-L. Drapé; Paris/FR
M. Epermane; Valmiera/LV
G. Guglielmi; Foggia/IT
G. Mantzikopoulos; Athens/GR
A. Oktay; Izmir/TR
C.W.A. Pfirrmann; Zurich/CH
S. Weckbach; Munich/DE
Paediatric
The ESR would like to thank ESPR for
Chairman:
J.-F. Chateil; Bordeaux/FR
Members:
A. Borthne; Lørenskog/NO
M.P. García-Peña; Barcelona/ES
M. Haliloglu; Ankara/TR
C.J. Kellenberger; Zurich/CH
O.E. Olsen; London/UK
S. Ryan; Dublin/IE
R.R. van Rijn; Amsterdam/NL
Members:
S. Braico; Rome/IT
P. Gerson; Paris/FR
A. Henner; Oulu/FI
D. Pekarovic; Ljubljana/SI
K. Sigurdardottir; Mosfellbaer/IS
C. Vandulek; Kaposvár/HU
Vascular
The ESR would like to thank CIRSE for
Chairman:
W.R. Jaschke; Innsbruck/AT
Members:
E. Brountzos; Athens/GR
A. Cieszanowski; Warsaw/PL
M.W. de Haan; Maastricht/NL
F. Fanelli; Rome/IT
J.E. Jackson; London/UK
T.J. Kroencke; Berlin/DE
L.P. Lawler; Dublin/IE
F. Thony; Grenoble/FR
The ESR would like to thank EFOMP for
Chairman:
Members:
O. Ciraj-Bjelac; Belgrade/RS
E. Guibelalde; Madrid/ES
H. Jarvinen; Helsinki/ FI
R. Padovani; Udine/IT
O. Speck; Magdeburg/DE
D.G. Sutton; Dundee/UK
J.N. Vassileva; Sofia/BG
103
What if you could improve
diagnostic and treatment
efﬁciency in a new way?
Visit us at
ECR 2011
Hall Extension
Expo A,
Austria Center
Vienna
Morphological and functional information in one image,
on one screen. For profound diagnosis and treatment.
With Siemens, you can easily see the complete clinical picture and compare current results with what you have
diagnosed before. Acquire morphological, functional, and metabolic images simultaneously as you have never
done before. Bring together PET∙CT, MR, CT, Angiography, and X-ray on one screen, in one layout with syngo.via*.
Compare current and previous results in an instant – allowing you to increase treatment precision and efficiency
in a new way. Images, my way. www.siemens.com/ecr
Answers for life.
A91IM-9128-A1-ECR
* syngo.via can be used as a stand-alone device or together with a variety of syngo.via-based software options, which are medical devices in their own rights.
ECR 2011
Topic Coordinators
Categorical Courses
E³ – European Excellence in Education
KISS (Keep it simple and straightforward):
Musculoskeletal MRI
A.M. Davies; Birmingham/UK
Foundation Course: Paediatric Radiology
V. Donoghue; Dublin/IE
Radiology in Abdominal Emergencies
B. Hamm; Berlin/DE
P. Rogalla; Berlin/DE
CLICK (Clinical lessons for imaging core knowledge):
Update Your Skills (Practical Courses)
Image-Guided Breast Biopsy: How to do it
M.H. Fuchsjäger; Vienna/AT
Mini Courses
Musculoskeletal US: Shoulder and elbow
Organs from A to Z: Pancreas
The Beauty of Basic Knowledge:
H.-C. Becker; Munich/DE
Functional Imaging of Tumours: How to do it
C.A. Cuénod; Paris/FR
Joint Course of ESR and RSNA
(Radiological Society of North America):
Essentials in oncologic imaging:
what radiologists need to know
R.L. Baron; Chicago, IL/US
Y. Menu; Paris/FR
D.M. Panicek; New York, NY/US
105
Register online now at
www.myESR.org/registration2011

Scientific - myESR.org

Transcription

Similar documents

Call today! 215 • 676 • 5100

The ideal solution for radiology, Mammography, and

Emeryville Advanced Imaging Referral Form Back

TESCAN MIRA3 XMU VP

RIMI Capabilities Patient Brochure

Maryam Rahmani MD

radiology - Health Careers

IDenticard Literature - Commercial Systems Group

New... - Cranel Imaging

Radiology Sheet - Zotec Partners